0001437749-21-025797.txt : 20211109 0001437749-21-025797.hdr.sgml : 20211109 20211109093030 ACCESSION NUMBER: 0001437749-21-025797 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 47 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211109 DATE AS OF CHANGE: 20211109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULUS VISIONTECH INC. CENTRAL INDEX KEY: 0001107280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061576391 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-29651 FILM NUMBER: 211390164 BUSINESS ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 BUSINESS PHONE: 6046851017 MAIL ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 FORMER COMPANY: FORMER CONFORMED NAME: OCULUS VISION TECH INC. DATE OF NAME CHANGE: 20120201 FORMER COMPANY: FORMER CONFORMED NAME: USA VIDEO INTERACTIVE CORP DATE OF NAME CHANGE: 20000217 10-Q 1 ovtz20210930_10q.htm FORM 10-Q ovtz20210930_10q.htm
0001107280 OCULUS VISIONTECH INC. false --12-31 Q3 2021 0 0 250,000,000 250,000,000 0 0 0 0 500,000,000 500,000,000 91,422,569 91,422,569 86,522,569 86,522,569 0.01 12,500,000 5 0 0 500,000,000 0.80 3,920,000 1.00 2.50 45,500 10 1.20 424,300 125 0.14 0 230,604 0.80 211,700 120.80 0.25 0 0.8000 59,248 0.35 909,900 125 0.27 0 0.35 369,597 334,385 0.45 75,800 125 0.02 0 1,899 43,439 00011072802021-01-012021-09-30 xbrli:shares 00011072802021-11-09 iso4217:USD 00011072802021-09-30 00011072802020-12-31 iso4217:USDxbrli:shares 00011072802021-07-012021-09-30 00011072802020-07-012020-09-30 00011072802020-01-012020-09-30 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2019-12-31 0001107280ovtz:CommitmentToIssueSharesMember2019-12-31 0001107280us-gaap:RetainedEarningsMember2019-12-31 00011072802019-12-31 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-01-012020-09-30 0001107280ovtz:CommitmentToIssueSharesMember2020-01-012020-09-30 0001107280us-gaap:RetainedEarningsMember2020-01-012020-09-30 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-09-30 0001107280ovtz:CommitmentToIssueSharesMember2020-09-30 0001107280us-gaap:RetainedEarningsMember2020-09-30 00011072802020-09-30 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2020-12-31 0001107280ovtz:CommitmentToIssueSharesMember2020-12-31 0001107280us-gaap:RetainedEarningsMember2020-12-31 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-01-012021-09-30 0001107280ovtz:CommitmentToIssueSharesMember2021-01-012021-09-30 0001107280us-gaap:RetainedEarningsMember2021-01-012021-09-30 0001107280us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-09-30 0001107280ovtz:CommitmentToIssueSharesMember2021-09-30 0001107280us-gaap:RetainedEarningsMember2021-09-30 00011072802020-01-012020-12-31 00011072802019-01-012019-12-31 xbrli:pure 0001107280ovtz:OCLTechnologiesCorpMember2020-12-31 0001107280ovtz:OCLTechnologiesCorpMember2020-01-012020-12-31 0001107280ovtz:OCLTechnologiesCorpMemberovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember2020-12-31 0001107280ovtz:OCLTechnologiesCorpMemberovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember2020-01-012020-12-31 utr:Y 0001107280ovtz:OCLTechnologiesCorpMember2020-06-052020-06-05 iso4217:CADxbrli:shares 0001107280ovtz:OCLTechnologiesCorpMember2020-06-05 0001107280ovtz:InvestorsMember2020-06-052020-06-05 0001107280ovtz:EmployeeAndDirectorsMember2020-06-052020-06-05 0001107280ovtz:InvestorsMember2020-06-05 0001107280us-gaap:PrivatePlacementMember2021-06-142021-06-14 iso4217:CAD 0001107280us-gaap:PrivatePlacementMember2021-06-14 0001107280ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember2021-06-14 utr:M 0001107280ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember2021-06-142021-06-14 0001107280ovtz:RollingStockOptionPlanMember2020-12-31 0001107280ovtz:RollingStockOptionPlanMember2021-09-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2021-01-292021-01-29 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2021-01-29 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-01-292021-01-29 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2021-01-012021-09-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-01-012021-06-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-06-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-09-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-01-012021-09-30 0001107280us-gaap:EmployeeStockOptionMemberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-01-012021-09-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2020-07-212020-07-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2020-07-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2021-07-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2021-07-212021-07-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2020-07-212020-07-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2021-01-012021-09-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-12-212020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2020-12-212020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2021-01-012021-09-30 0001107280ovtz:Covid19Member2021-01-012021-09-30
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from             to            

 

Commission File Number: 0-29651

oculusvision.jpg

OCULUS VISIONTECH INC.

(Exact name of registrant as specified in its charter)

 

Wyoming

06-1576391

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

 

Suite 507 - 837 West Hastings Street, Vancouver, BC, Canada, V6C 3N6

(Address of principal executive offices) (Zip code)

 

(604) 685-1017

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes   ☑      No   ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes    ☑      No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” ‘‘accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer     

Smaller reporting company   

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes          No ☑

 

As at November 9, 2021, there were 91,422,569 shares of the registrant’s common stock outstanding

 

 

1

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common

  

Common stock - no par value

OVTZ

Over The Counter Bulletin Board

Preferred stock - no par value

N/A

N/A

Common stock - no par value

OVT

TSX Venture Exchange

Common stock - no par value

USF1

Frankfurt Stock Exchange

 

2

 

 

TABLE OF CONTENTS

 

   

PART I  FINANCIAL INFORMATION

 
   

Forward Looking Statements

4

Item 1.  

 

Financial Statements

6

   

Condensed Interim Consolidated Balance Sheets

6

 

(A)

Condensed Interim Consolidated Statements of Operations

7

 

(B)

Condensed Interim Consolidated Statements Of Stockholders Equity (Deficiency) 

8

 

(C)

Condensed Interim Consolidated Statements of Cash Flows

9

 

(D)

Notes to Condensed Interim Consolidated Financial Statements

10

Item 2.  

(E)

Managements Discussion and Analysis of Financial Condition and Results of Operations

13

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

18

Item 4.

 

Controls and Procedures

18

       
   

PART II  OTHER INFORMATION

 
       

Item 1.  

 

Legal Proceedings

19

Item 1A.

 

Risk Factors

19

Item 2.     

 

Unregistered Sales of Equity Securities and Use of Proceeds

19

Item 3.

 

Defaults Upon Senior Securities

19

Item 4.

 

Mine Safety Disclosure

19

Item 5.

 

Other Information

19

Item 6.

 

Exhibits

19

 

3

 

 

 

FORWARD LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical fact are “forward-looking statements” for the purposes of this Quarterly Report on Form 10-Q. In some cases, you can identify these statements by forward-looking words such as “plan”, “may”, “will”, “expect”, “intend”, “anticipate”, believe”, “estimate” and “continue” or similar words. Forward-looking statements are statements that are not historical facts, and include, but are not limited to:
 

 

statements regarding our products and services, including:

 

o

our digital watermarking technology and Cloud-based document protection system;

 

o

our data privacy and data protection services and solutions; our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements;

 

o

our expectations regarding competition and growth in our sector; o the future sources and availability of additional funding; and

 

o

the effect of funding arrangements on projects and products.

 

You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Accordingly, we do not undertake any obligation to update any forward-looking statements for any reason, even if new information becomes available or other events occur in the future, except as required by law.

 

Forward-looking statements are based on current expectations about future events affecting the Company and are subject to uncertainties and factors that affect all business operating in a global market as well as matters specific to the Company. These uncertainties and factors are difficult to predict, and many of them are beyond the Company’s control. Factors to consider when evaluating these forward-looking statements include, but are not limited to:

 

 

the impact of pandemics;

 

the Company’s limited operating history makes it difficult to evaluate its business and prospects;

 

the Company has incurred substantial losses and expects to incur losses in the future and may never achieve profitability;

 

if the Company is unable to obtain substantial additional financing, it may not be able to remain in business;

 

the Company’s operating results in future periods are expected to be subject to significant fluctuations, which would likely affect the trading price of the Company’s common shares;

 

the data privacy and data protection markets are highly competitive, and the Company’s failure to successfully compete will limit its ability to attain, retain and increase its market share;

 

the document protection market is highly competitive, and the Company’s failure to compete successfully would limit its ability to retain and increase its market share;

 

the video digital watermarking business is highly competitive, and the Company’s failure to compete successfully would limit its ability to retain and increase its market share;

 

the Company is subject to rapid technological change, which could render its products and services obsolete;

 

the Company is dependent upon vendors and other third-party service providers and will be competing with some of these companies;

 

the Company’s services are technically complex and it may not be able to prevent defects that could decrease their market acceptance, result in product liability or harm its reputation;

 

any loss of the Company’s personnel or inability to acquire new personnel could harm its business;

 

failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have material adverse effect on the Company’s business and operating results and shareholders could lose confidence in the Company’s financial reporting;

 

the Company does not currently have any paying customers;

 

the Company’s business may suffer if it cannot protect its intellectual property;

 

the Company’s products may infringe the intellectual property rights of others, causing the Company to incur significant costs or prevent us from licensing its products;

 

the Company’s success depends on the continued growth in demand for e-business applications;

 

government regulation and legal uncertainties could add additional costs and risks to doing business on the Internet;

 

the Company’s share price has been and could be highly volatile, which could result in substantial losses to investors;

 

the Company has not paid cash dividends in the past and does not expect to pay cash dividends in the foreseeable future.

 

4

 

 

Any return on investment may be limited to the value of the Company’s common shares;

 

securities analysts may not initiate coverage or continue to cover the Company’s common shares, and this may have a negative impact on its market price;

 

anti-takeover provisions in our charter documents could prevent or delay a change in control of the Company; LEGAL_36260802.1

 

the Company intends to issue additional equity securities, which may dilute the interests of current shareholders or carry rights or preferences senior to the common shares;

 

the exercise of options and warrants and other issuances of common shares or securities convertible into or exercisable for common shares will dilute the ownership interest of the Company’s current shareholders and may adversely affect the future market price of the Company’s common shares;

 

limited liability of executive officers and directors may discourage shareholders from bringing a lawsuit against them;

 

requirements of the SEC with regard to low-priced “penny stocks” may adversely affect the ability of shareholders to sell their shares in the secondary market;

 

the Company does not anticipate paying dividends to shareholders in the foreseeable future;

 

the Company may be exposed to adverse currency exchange rate fluctuations, which could harm the Company’s financial results and cash flows;

 

service outages and disruption of the Company’s infrastructure may harm the Company and adversely impact business operations and injure reputation;

 

security vulnerabilities in the Company’s products and services or any breach of the Company’s security measures may injure its reputation and disrupt the Company’s business;

 

the financial reporting obligations of being a public company in the United States are expensive, time consuming, and may place significant demands on the Company’s management; and

 

the Company’s failure to manage or adequately address any one or more of these risks could result in the business suffering a material adverse effect.

 

The Company believes the items outlined above are important factors that could cause estimates included in its financial statements to differ materially from the actual results and those expressed in a forward-looking statement made in this report or elsewhere by the Company or on its behalf. The Company has discussed these factors in more detail under “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and other periodic reports filed with the United States Securities and Exchange Commission (“SEC”). Accordingly, to the extent that this quarterly report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company’s actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements. We do not intend to update our description of important factors each time a potential important factor arises, except as required by applicable securities laws and regulations. We advise our shareholders that they should (i) be aware that factors not referred to above could affect the accuracy of the Company’s forward-looking statements and (ii) use caution when considering the Company’s forward-looking statements.

 

5

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

(Unaudited)

 


 

  

September 30,

  

December 31,

 
  

2021

  

2020

 
  

(unaudited)

  

(audited)

 

ASSETS

        
         

Current Assets:

        

Cash and cash equivalents

 $2,706,660  $490,190 

Prepaid expenses and other current assets

  9,482   6,082 

Total Assets

 $2,716,142  $496,272 
         

LIABILITIES AND STOCKHOLDERS' EQUITY

        
         

Current Liabilities:

        

Accounts payable and accrued expenses

 $109,084  $32,329 

Accounts payable and accrued expenses - related parties

  135,759   135,738 

Total current liabilities

  244,843   168,067 
         

Commitments and Contingencies

   -    - 
         

Stockholders' Equity:

        

Preferred stock - no par value; authorized 250,000,000 shares, none issued

        

Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 86,522,569

  47,672,522   44,073,257 

Commitment to issue shares

  414,128   414,128 

Accumulated deficit

  (45,615,351

)

  (44,159,180

)

Stockholders' equity

  2,471,299   328,205 

Total Liabilities and Stockholders' Equity

 $2,716,142  $496,272 

 

SEE ACCOMPANYING NOTES

 

6

 
 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(Stated in US Dollars)

(Unaudited)

 


 

  

For the three months ended

September 30,

  

For the nine months ended

September 30,

 
  

2021

  

2020

  

2021

  

2020

 
                 

Revenue

 $-  $-  $-  $- 
                 

Expenses:

                

Consulting

  -   -   24,021   - 

Research and development

  295,830   93,270   575,999   130,180 

Selling, general and administrative (Note 8)

  113,607   83,605   319,132   204,447 

Stock-based compensation (Note 7)

  169,373   120,098   537,019   120,098 
                 

Total expenses

  578,810   296,973   1,456,171   454,725 

Loss from operations

  (578,810)  (296,973)  (1,456,171)  (454,725)
                 

Other income

                

Interest income

  -   -   -   96 
   -   -   -   96 
                 

Net loss

 $(578,810) $(296,973) $(1,456,171) $(454,629)
                 

Net loss per share - basic and diluted

 $(0.01) $(0.00) $(0.02) $(0.01)
                 

Weighted average number of common shares outstanding – basic and diluted

  91,422,569   86,522,569   89,476,981   78,165,426 

 

SEE ACCOMPANYING NOTES

 

7

 
 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Stated in US Dollars)

(Unaudited)

 


 

 

Common Stock and             

 

Additional Paid in             

 

Capital             
         

Commitment to

  

Accumulated

  

Stockholders'

 

   

Shares  

Amount

  

Issue Shares

  

Deficit

  

Equity

 
                    
                    

Balance at January 1, 2020

 67,022,568  $41,634,999  $-  $(41,386,696) $248,303 
                    

Sale of common stock

 7,000,001   773,038   -   -   773,038 

Shares issued for asset acquisition

 12,500,000   1,380,427   -   -   1,380,427 

Contingent consideration

 -   -   414,128   -   414,128 

Share-based compensation

 -   120,098   -   -   120,098 

Net loss

 -   -   -   (454,629)  (454,629)
                    

Balance at September 30, 2020

 86,522,569  $43,908,562  $414,128  $(41,841,325) $2,481,365 
                    

Balance at January 1, 2021

 86,522,569  $44,073,257  $414,128  $(44,159,180) $328,205 
                    

Sale of common stock

 4,900,000   3,098,616   -   -   3,098,616 

Share issuance costs - cash

 -   (36,370)  -   -   (36,370)

Share-based compensation

 -   537,019   -   -   537,019 

Net loss

 -   -   -   (1,456,171)  (1,456,171)
                    

Balance at September 30, 2021

 91,422,569  $47,672,522  $414,128  $(45,615,351) $2,471,299 

 

8

 
 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars)

(Unaudited)

 


 

Nine months ended September 30,

 

2021

  

2020

 
         

Cash flows from operating activities:

        

Net loss

 $(1,456,171

)

 $(454,629

)

Add back non-cash share-based compensation

  537,019   120,098 

Adjustments to reconcile net loss to net cash used in operating activities:

        

Changes in operating assets and liabilities:

        

Decrease in prepaid expenses and other current assets

  (3,400)  (3,419

)

Decrease (increase) in accounts payable and accrued expenses

  76,755   (241,373

)

Decrease (increase) in accounts payable and accrued expenses due to related parties

  21   5,499 
         

Net cash used in operating activities

  (845,776

)

  (573,824

)

         

Cash flows from operating activities:

        

Cash acquired on asset acquisition

  -   114,169 
         

Net cash provided by investing activities

  -   114,169 
         

Cash flows from operating activities:

        

Proceeds from sale of common stock

  3,098,616   773,038 

Share issuance costs

  (36,370)  - 
         

Net cash provided by financing activities

  3,062,246   773,038 
         

Net decrease in cash and cash equivalents

  2,216,470   313,383 
         

Cash and cash equivalents at beginning of period

  490,190   382,452 

Cash and cash equivalents at end of period

 $2,706,660  $695,835 
         
         

Supplemental disclosures of cash flow information:

        
         

Cash paid during the period for interest

 $-  $- 

Cash paid during the period for income taxes

 $-  $- 
         

Non-cash financing and investing activities

        

Common stock issued on acquisition

 $-  $1,380,427 

Intangible acquired on acquisition

 $-  $(1,966,939

)

Warrants issued on acquisition

 $-  $414,128 

Account payable acquired on acquisition

 $-  $172,384 
         
  $-  $- 

 

SEE ACCOMPANYING NOTES

 

9

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021 and 2020 

(Stated in US Dollars)

(Unaudited)

 

 

1.

BASIS OF PRESENTATION AND BUSINESS

 

These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended December 31, 2020. These unaudited condensed interim consolidated financial statements do not include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended December 31, 2020, except when disclosed below.

 

The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, ComplyTrust® Inc. (formerly OCL Technologies Corp.) (from the date of acquisition, Note 5). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are not necessarily indicative of the results that may be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2020.

 

Oculus VisionTech, Inc. (the "Company") is a designer of digital watermarking services and solutions. At September 30, 2021 and fiscal 2020, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

 

 

2.

GOING CONCERN

 

The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of $1,456,171 for the nine month period ended September 30, 2021 and, in addition the Company incurred losses of $2,772,484 and $192,865 for the year ended December 31, 2020 and 2019. As of September 30, 2021, the Company had an accumulated deficit of $45,615,351 and a working capital of $2,471,299. These conditions raise doubt about the Company’s ability to continue as a going concern.  The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.

 

 

3.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

  

September 30,

2021

  

December 31,

2020

 
         

Prepaid expenses

 $2,403  $1,030 

Tax Receivable – Canadian GST

  7,079   5,052 
  $9,482  $6,082 

 

10

 
 
 

4.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

  

September 30,

2021

  

December 31,

2020

 
         

Accounts payable

 $60,000  $16,670 

Accrued fees and expenses

  49,084   15,659 
  $109,084  $32,329 

 

Accounts payable and accrued expenses – related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.

 

 

5.

ACQUISITION OF COMPLYTRUST INC. (FORMERLY OCL TECHNOLOGIES CORP.)

 

During the year ended December 31, 2020, the Company acquired a 100% interest in ComplyTrust Inc. (formerly OCL Technologies Corp.) (“CTI”) by issuing 12,500,000 shares with a fair value of $1,380,427 and contingent consideration consisting of 12,500,000 non-transferable warrants with a fair value of $414,128. The transaction does not meet the definition of a business as defined in ASC 805-10. As a result, the acquisition of CTI has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, CTI became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:

 

     

Purchase Price

    
     

Issuance of 12,500,000 shares

 $1,380,427 

Contingent consideration – warrants

  414,128 

Transaction costs

  54,532 
     

Total Purchase Price

 $1,849,087 

 

Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five years from the date of issuance expiry June 4, 2025. No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per CTI’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.

 

     

Purchase Price Allocation

    
     

Cash

 $114,169 

Accounts payable and due from related party

  (232,021

)

Intangible asset

  1,966,939 
     

Total Purchase Price

 $1,849,087 

 

During the year ended December 31, 2020, the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of $1,966,939.

 

11

 
 
 

6.

COMMON STOCK 

 

The Company has one class of no par value common stock with 500,000,000 authorized shares 91,422,569 and 86,522,569 outstanding on September 30, 2021 and December 31, 2020, respectively.

 

On June 5, 2020, the Company issued 12,500,000 shares at a value of $0.15 CDN per share pursuant to the acquisition of OCL Technologies Corp.

 

On June 5, 2020, the Company issued 7,000,001 shares to investors, including 1,766,667 common shares to a consultant and directors at $0.15 CDN per share.

 

On June 14, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of $3,920,000CDN ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of $1.00CDN for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than $2.50CDN for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid $45,500CDN ($36,370) as share issuance costs.

 

 

7.

STOCK OPTIONS  

 

During the period ended September 30, 2021 and year ended December 31, 2020, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options.

 

During the period ended September 30, 2021, the Company:

 

i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CDN and an expiry date of January 29, 2024. The options have a fair value of $424,300CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.14%; (iv) Dividend rate of Nil; and (v) market stock price of $1.18. The options vest 20% every 6 months starting July 29, 2021. During the period ended September 30, 2021, the Company recorded $230,604CND ($186,627) of stock-based compensation relating to the vesting period.

 

i) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of $0.80CDN and an expiry date of June 10, 2024. The options have a fair value of $211,700CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 120.80%; (ii) Term of 3 years; (iii) Discount rate of 0.25%; (iv) Dividend rate of Nil; and (v) market stock price of $0.8000CDN. The options vest 20% every 6 months starting December 10, 2021. During the period ended September 30, 2021, the Company recorded $59,248CDN ($48,592) of stock-based compensation relating to the vesting period.

 

During the year ended December 31, 2020, the Company:

 

i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CDN and an expiry date of July 21, 2023. The options have a fair value of $909,900CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35. The options vest 20% every 6 months starting January 21, 2020. During the year ended December 31, 2020, the Company recorded $369,597CDN ($283,307) of stock-based compensation relating to the vesting period. During the period ended September 30, 2021, the Company recorded $334,385CDN ($267,221) of stock-based compensation relating to the vesting period.

 

ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CDN and an expiry date of December 21, 2023. The options have a fair value of $75,800CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.02%; (iv) Dividend rate of Nil; and (v) market stock price of $0.425. The options vest 20% every 6 months starting June 21, 2021. During the year ended December 31, 2020, the Company recorded $1,899CDN ($1,486) of stock-based compensation relating to the vesting period. During the period ended September 30, 2021, the Company recorded $43,439CDN ($34,579) of stock-based compensation relating to the vesting period.

 

12

 
 
 

8.

SELLING, GENERAL AND ADMINISTRATIVE

 

The breakdown of selling, general and administrative for the period ended September 30, 2021 as follows:

 

     

Filing and regulatory fees

 $26,731 

Marketing

  31,374 

Professional fees

  102,870 

Rent

  29,857 

Office and administration

  128,300 
     
  $319,132 

 

 

9.

COVID-19  

 

In early 2020, a coronavirus that causes COVID-19 emerged globally, which is currently affecting the global economies and has a resulting effect on the Company.  Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.

 

 

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations.

 

FORWARD-LOOKING STATEMENTS AND SUPPLEMENTARY DATA

 

The following discussion should be read in conjunction with our condensed interim financial statements and other financial information appearing elsewhere in this quarterly report. In addition to historical information, the following discussion and other parts of this quarterly report contain forward-looking statements under applicable securities laws. You can identify these statements by forward-looking words such as “plan”, “may”, “will”, “expect”, “intend”, “anticipate”, believe”, “estimate” and “continue” or similar words. Forward-looking statements are statements that are not historical facts, and include, but are not limited to, statements regarding our products and services, including our digital watermarking technology and Cloud-based document protection system, our data privacy and data protection services and solutions, our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements, and our expectations regarding competition and growth in our sector, are forward looking statements, the future sources and availability of additional funding, and the effect of funding arrangements on projects and products. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Accordingly, we do not undertake any obligation to update any forward-looking statements for any reason, even if new information becomes available or other events occur in the future, except as required by law.

 

The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties set forth under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and other periodic reports filed with the United States Securities and Exchange Commission (“SEC”). Accordingly, to the extent that this quarterly report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company’s actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements.

 

OVERVIEW OF THE COMPANY

 

Oculus VisionTech Inc. (OVTZ) is a Canadian-based development-stage technology company focused on cyber security, data privacy and data protection solutions for Enterprise business customers. Headquartered in Vancouver, British Columbia, Canada, the company was originally founded by image processing experts and is operated by experienced leadership. Currently, OVTZ is expanding and investing in a suite of new data protection and data privacy security products that will revolutionize CCPA, GDPR, LGPD and other data privacy legislation compliance for both data subjects and data controllers worldwide. Our mission is innovation of viable software tools that enable intelligent automated solutions for public cloud customer services and needs specific to data privacy and data protection for individuals, organizations and their customers worldwide, through a vision of mutually trusted data compliance.

 

13

 

Our Forget-Me-Yes® data privacy product is a Software-as-a-Service (SaaS) platform developed to specifically address the global ‘Right-to-be-Forgotten’ (RtbF) and Right-of-Erase (RoE) legal components of Brazil’s LGPD, Europe’s GDPR, California Consumer Privacy Act (CCPA), Colorado Privacy Act (CPA) and Virginia CDPA data privacy compliance. An additional new data protection software tool, ComplyScanTM, is being developed to address public cloud data compliance governance. Our legacy Cloud Document Protection System (Cloud-DPS) technology leveraged our digital watermarking technology to enable OVTZ to offer a SaaS-based document management platform for tamper-proof document authentication and protection. Historically, we have used our digital watermarking technology for streaming video content distribution based on embedded digital watermarking, as well as video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity.

 

We were incorporated on April 18, 1986, as "First Commercial Financial Group Inc." in the Province of Alberta, Canada. In 1989, our name was changed to "Micron Metals Canada Corp.", which purchased 100% of the outstanding shares of USA Video Inc., a Texas corporation, in order to focus on the digital media business. In 1995, we changed our name to "USA Video Interactive Corp." and continued out of the Province of Alberta into the State of Wyoming. At a shareholders meeting held on December 30, 2011, a resolution was passed to change our name to "Oculus VisionTech Inc." and to alter our share capital by way of a reverse stock split (share consolidation) on the basis of fifteen old common shares for one new common share. On January 25, 2012, we changed our name to "Oculus VisionTech Inc." In June 2020, OVTZ acquired OCL Technologies Inc. (OCL), a Delaware corporation data privacy software development startup based in San Diego, California. As a 100% wholly-owned subsidiary of OVTZ and to better align with customer and market focus, OCL has completed a corporate name change to ComplyTrust® Inc. (CTI) on January 21, 2021. All OCL references throughout this document are synonymous with the new name change, CTI.

 

Our executive and corporate headquarter offices are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia, Canada, V6C 3N6. Our telephone number is 1-800-684-0183 and our facsimile number is 604-685-5777. Our email address is contact@ovtz.com and our website is www.ovtz.com. Our common shares are listed for trading on the TSX Venture Exchange (TSX.V – OVT, OTCQB – OVTZ, FSE – USF1).

 

BUSINESS OBJECTIVES:

 

In this age of digital transformation, data monetization, IoT, and massive data migration to converged hyperscale, geo-disbursed Cloud infrastructure and workloads, data protection and data privacy have taken center stage. GDPR, LGPD, CCPA, and many other new international (China/PIPL, India) and upcoming US data privacy regulations enable individuals and organizations the right to access and request deletion of all personal information for a given data subject. In our ever increasing Everything-as-a-Service world, OVTZ recognizes the need for global cloud-native data privacy and data protection solutions that are multi-cloud platform-ready and can augment both existing legacy and newer agile-driven architectures. OVTZ is building modular microservices-based software solutions and services for both hybrid on-premise and multi-cloud data management that incorporate automated malware, privacy and ransomware scanning, reporting and visualization.

 

Our new Forget-Me-Yes® (FMY) Software-as-a-Service (SaaS) data privacy solution is a secure, Zero-Knowledge platform providing a single-source capability of continuous ‘right-to-be-forgotten’ (RtbF) and ‘right-of-erase’ (RoE) privacy compliance by incorporating automated policy-driven re-query services that guarantees a Data Subject’s requested RtbF/RoE data remains ‘forgotten’ over the life of their FMY subscription. FMY incorporates hybrid polymorphic encryption technology that ensures all User Interface, data-in-transit and data-at-rest remain secure and can only be accessed by the subscriber. With a cloud-native architecture, the FMY functionality can be utilized as either a complete turnkey SaaS subscription platform, or individually licensed for seamless integration with existing 3rd. party applications and data privacy platforms.

 

Our new ComplyTrust® Software-as-a-Service Suite (CTSS) is a set of software tools specifically designed to address cloud-native data management and regulatory compliant data governance. CTSS will help to remove enterprise organizational barriers and blockers to further enable successful cloud migration and deployment that benefit the cloud infrastructure providers, enterprise organizations, and users collectively. CTSS helps to automate and visualize cloud compliance reporting across accounts, regions and services based on a variety of user-definable and data driven metrics. Development of the first CTSS product, a cloud-native data backup compliance reporting tool called ComplyScanTM (CS), has commenced.

 

OVTZ had recognized that cloud-based, digital document security/protection products were a potentially viable business opportunity for the Company that allowed us to apply our proprietary real-time digital video watermarking technology, originally developed for studios and networks in the entertainment industry, to the digital document security/protection market. Cloud-DPS secures and protects digital documents (including text documents, photos, blueprints, etc.) from any modification, and/or attempted forgery by imperceptibly watermarking documents, using real-time image processing and watermarking algorithms, embedded into a secured/protected copy of a document. This authentication and verification process ensures the integrity of the original digital document.

 

14

 

 

Our near-term business objectives for the above:

 

1.

Patent and license new technology developed within the corporate research and development program;

 

2.

Demonstrate proof of concept on selected commercial projects with our Forget-Me-Yes® (FMY) data privacy Software-as-a-Service (SaaS) platform and ComplyTrust® SaaS Suite (CTSS), gain industry recognition for the architectural and business differentiators of the company’s FMY data privacy, CS reporting tool, and our legacy C-DPS authentication/tamper-proof functionality product’s, and generate sales and support revenues in FY21+.

 

CRITICAL ACCOUNTING POLICIES (AND ESTIMATES)

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate these estimates, including those related to customer programs and incentives, bad debts, inventories, investments, intangible assets, income taxes, warranty obligations, impairment or disposal of long-lived assets, contingencies and litigation.  We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

 

We have identified the policies below as critical to our business operations and to the understanding of our financial results. The impact and any associated risks related to these policies on our business operations is discussed throughout management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results:

 

 

Revenue recognition;

 

Impairment or disposal of long-lived assets;

 

Deferred taxes;

 

Accounting for stock-based compensation; and

 

Commitments and contingencies.

 

Revenue Recognition.  In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC 606"). This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers to depict the transfer of control over a product to a customer. The guidance's core principle is that the Company will recognize revenue when it transfers control over promised goods or services to customers in an amount that reflects consideration to which the Company expects to be entitled in exchange for those goods or services.

 

Under ASC 606, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to a customer. The Company's contracts with customers typically contain a single performance obligation. A contract's transaction price is allocated to its distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. If there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on their relative standalone selling prices. Sales are recorded net of sales returns, discounts and allowances.

 

Impairment or Disposal of Long-Lived Assets.  Long-lived assets are reviewed in accordance with ASC Topic 360-10-05.  Impairment or disposal of long-lived assets losses are recognized in the period the impairment or disposal occurs.  

 

Deferred Taxes.  We record a valuation allowance to reduce deferred tax assets when it is more likely than not that some portion of the amount may not be realized.  

 

Accounting for Stock-Based Compensation.  Under ASC Topic 718, Stock Compensation (formerly referred to as SFAS No. 123(R)), the Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of the Company’s common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments.

 

15

 

 

Commitments and Contingencies.  We account for commitments and contingencies in accordance with ASC Topic 450 Contingencies (formerly referred to as financial accounting standards board Statement No. 5, Accounting for Contingencies). We record a liability for commitments and contingencies when the amount is both probable and reasonably estimable.

 

RESULTS OF OPERATIONS

 

Sales

 

Sales for the nine and three month period ended September 30, 2021 and 2020 were $-0-

 

Cost of Sales

 

The cost of sales for the nine and three months ended September 30, 2021 and 2020 were $-0-.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses, consisting of product marketing expenses, consulting fees, office, professional fees and other expenses to execute our business plan and for our day-to-day operations, increased in the period ended September 30, 2021.  

 

We continue to develop and have begun to market the Forget-Me-Yes® (FMY) “Right-to-be-Forgotten” and “Right-of-Erase” data privacy platform. Administrative expenses have decreased/increased moderately as a result of insignificant fluctuations in general costs.

 

Nine month period ended September 30, 2021

 

Selling, general and administrative expenses for the period ended September 30, 2021 increased to $319,132 from $204,447 for the period ended September 30, 2020. We incurred increased costs in 2021 due to post acquisition legal and accounting costs.

 

Three month period ended September 30, 2021

 

Selling, general and administrative expenses for the period ended September 30, 2021 increased to $113,607 from $83,605 for the period ended September 30, 2020. We incurred increased costs in 2021 due to post acquisition legal and accounting costs.

 

We have arranged for additional staff and consultants to engage in marketing activities in an effort to identify and assess appropriate market segments, develop business arrangements with prospective partners, create awareness of new products and services, and communicate to the industry and potential customers. Other components of selling, general and administrative expenses did not change significantly.

 

Research and Development

 

Nine month period ended September 30, 2021

 

Research and development costs for the nine months ended September 30, 2021, increased to $575,999 from $130,108 for the comparable period. We incurred increased costs in 2021 due to management’s decision to continued on-going development of the Forget-Me-Yes® (FMY) data privacy solution and initiated development of the new CTSS ComplyScanTM backup reporting tool, while evaluating the legacy C-DPS architecture, addressable market and potential future integration into CTSS.

 

Three month period ended September 30, 2021

 

Research and development costs for the three months ended September 30, 2021, increased to $295,830 from $93,270 for the comparable period. We incurred increased costs in 2021 due to management’s decision to initiate development of the new CTSS ComplyScanTM data backup compliance reporting tool product and development of additional FMY data privacy connectors.

 

Net Losses

 

Nine month period ended September 30, 2021

 

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for the nine months ended September 30, 2021 was $1,456,171, compared with a net loss of $454,629 for the comparative period.

 

16

 

Three month period ended September 30, 2021

 

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for the nine months ended September 30, 2021 was $578,810, compared with a net loss of $296,973 for the comparative period.

 

Liquidity and Capital Resources

 

At September 30, 2021, our cash position was $2,706,660, compared to $490,190 at December 31, 2020. We had a working capital of $2,471,299 and an accumulated deficit of $45,645,351 at September 30, 2021.

 

On June 14, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of $3,920,000CDN ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of $1.00CDN for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than $2.50CDN for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid $45,500CDN ($36,370) as share issuance costs.

 

We have historically satisfied our capital needs primarily by issuing equity securities to our officers, directors, employees and a small group of investors, and from short-term bridge loans from members of management.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

As of September 30, 2021 we have no off-balance sheet arrangements.

 

17

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

 

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and is not required to provide information required under this Item.

 

Item 4.

Controls and Procedures.

 

We maintain “disclosure controls and procedures”, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

 

As of September 30, 2021, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting for the quarterly period ended September 30, 2021, identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15, that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

PART II - OTHER INFORMATION

 

Item 1.

Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

Item 1A.

Risk Factors.

 

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide information required under this Item. A description of the risks associated with our business, financial condition, and results of operations is set forth in Part I, Item 1A, of our Annual Report on Form 10 -K for the fiscal year ended December 31, 2019 filed with the SEC on September 30, 2021. Those factors continue to be meaningful for your evaluation of Oculus and we urge you to review and consider the risk factors presented in such Form 10-K.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3.

Defaults Upon Senior Securities.

 

None.

 

Item 4.

Mine Safety Disclosures.

 

Not applicable.

 

Item 5.

Other Information.

 

None.

 

Item 6.

Exhibits.

 

The information required by this Item is set forth on the exhibit index which follows the signature page of this report.

 

Exhibit

No.

 

Description

     

EX-31.1

 

Certification of CEO

     

EX-31.2

 

Certification of CFO

     

EX-32.1

 

SOX Certifiaction of CEO

     

EX-32.2

 

SOC Certification of CFO

 

101.INS

Inline XBRL Instance Document

   

101.SCH

Inline XBRL Taxonomy Extension Schema Document

   

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

   

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

   

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

   

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

   
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

19

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

OCULUS VISIONTECH INC.

     

November 9th, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

   

President and Chief Executive Officer

   

(principal executive officer)

     
     

November 9th, 2021

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

   

Chief Financial Officer

   

(principal financial and accounting officer)

 

20
EX-31.1 2 ex_303261.htm EXHIBIT 31.1 ex_303261.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Rowland Perkins, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc..;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9th, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_303262.htm EXHIBIT 31.2 ex_303262.htm

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anton J. Drescher, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 9th, 2021

By:

/s/ Anton J. Drescher

   

Anton J. Drescher

   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 
EX-32.1 4 ex_303263.htm EXHIBIT 32.1 ex_303263.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rowland Perkins, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 9th, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 
EX-32.2 5 ex_303264.htm EXHIBIT 32.2 ex_303264.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anton J. Drescher , Chief Financial Officer for the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 9th, 2021

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

 
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 
EX-101.SCH 6 ovtz-20210930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation and Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Common Stock link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Stock Options link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Selling, General and Administrative link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - COVID-19 link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 8 - Selling, General and Administrative (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 6 - Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 7 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 ovtz-20210930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ovtz-20210930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ovtz-20210930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Non-cash financing and investing activities us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) Note To Financial Statement Details Textual Intangible asset Note 3 - Prepaid Expenses and Other Current Assets Note 4 - Accounts Payable and Accrued Expenses Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) Note 8 - Selling, General and Administrative us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals) Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details) Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Notes To Financial Statements Cash Notes To Financial Statements [Abstract] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Add back non-cash share-based compensation us-gaap_LiabilitiesCurrent Total current liabilities Accounts payable and accrued expenses - related parties us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) Common stock issued on acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Total Purchase Price us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired us-gaap_SharesIssued Balance (in shares) Balance (in shares) us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share (in CAD per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) Stockholders' Equity Note Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) Tax Receivable – Canadian GST us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill), Total Warrants issued on acquisition (in shares) Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 86,522,569 Account payable acquired on acquisition Common stock, shares authorized (in shares) Common Stock, Shares Authorized (in shares) Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current, Total Common stock, shares issued (in shares) us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Intangible acquired on acquisition Common stock, no par value (in dollars per share) Common Stock, No Par Value (in dollars per share) us-gaap_AccountsPayableCurrent Accounts payable Preferred stock - no par value; authorized 250,000,000 shares, none issued Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Preferred stock, shares issued (in shares) Cash paid during the period for interest us-gaap_PolicyTextBlockAbstract Accounting Policies Prepaid expenses Cash paid during the period for income taxes Preferred stock, no par value (in dollars per share) Preferred stock, shares authorized (in shares) Unusual or Infrequent Item, or Both [Axis] Accrued fees and expenses Unusual or Infrequent Item, or Both [Domain] Revenue Unusual or Infrequent Items, or Both, Disclosure [Text Block] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Current Liabilities: Vesting [Axis] Vesting [Domain] us-gaap_Assets Total Assets Supplemental disclosures of cash flow information: Plan Name [Axis] Interest income Plan Name [Domain] Consulting The aggregate costs incurred for consultation. Other Assets Disclosure [Text Block] Rent Cash flows from operating activities: COVID-19 [Member] Represents COVID-19. ovtz_WorkingCapitalDeficit Working Capital (Deficit) Represents the amount of difference between Current Assets and Current Liabilities. Commitment to issue shares Warrants and Rights Outstanding Statement [Line Items] Mergers, Acquisitions and Dispositions Disclosures [Text Block] Commitment to Issue Shares [Member] Represents commitment to issue shares. Share-based Payment Arrangement [Text Block] Stockholders' Equity: us-gaap_NonoperatingIncomeExpense Nonoperating Income (Expense), Total Award Type [Domain] Net loss us-gaap_NetIncomeLoss Net Income (Loss) Attributable to Parent, Total Net loss Award Type [Axis] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period ASSETS Private Placement [Member] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash and cash equivalents us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Commitments and Contingencies Sale of Stock [Axis] Sale of Stock [Domain] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] us-gaap_OperatingIncomeLoss Loss from operations Share-based Payment Arrangement, Option [Member] Other income us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by investing activities ovtz_EquityOfferingPricePerUnitIssued Equity Offering, Price Per Unit Issued (in CAD per share) The price per unit issued in the equity offering. ovtz_EquityOfferingNumberOfCommonSharesPerUnit Equity Offering, Number of Common Shares Per Unit (in shares) The number of common shares per unit in the equity offering. ovtz_EquityOfferingNumberOfWarrantsPerUnit Equity Offering, Number of Warrants Per Unit (in shares) The number of warrant per unit in the equity offering. ovtz_ClassOfWarrantOfRightStockPriceTrigger Class of Warrant of Right, Stock Price Trigger (in CAD per share) Price of the entity's common stock which would be required to be attained for the conversion of warrant or right to be accelerated Counterparty Name [Axis] Counterparty Name [Domain] Warrants Issued in Connection with Private Placement [Member] Represents the warrants issued in connection with the private placement. ovtz_EquityOfferingNumberOfUnitsIssued Equity Offering, Number of Units Issued (in shares) The number of units issued during the period in the equity offering. ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays Class of Warrant or Right, Threshold Consecutive Trading Days Threshold period of specified consecutive trading days within which common stock price to conversion price of warrant or right must exceed threshold percentage for specified number of trading days to trigger conversion feature. Schedule of Business Acquisitions, by Acquisition [Table Text Block] Shares issued (in shares) Amount of equity interests of the acquirer in shares, including instruments or interests issued or issuable in consideration for the business combination. us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs Share issuance costs Investors [Member] Represents the investors of the company. Employee and Directors [Member] Represents the employee and directors of the company. us-gaap_CostsAndExpenses Total expenses us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity, Total Expenses: Retained Earnings [Member] ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Represents the fair value of options under the share-based compensation. Proceeds from sale of common stock Decrease (increase) in accounts payable and accrued expenses Common Stock Including Additional Paid in Capital [Member] Employee Stock Option, Expiration Date of July 21, 2023 [Member] Represents stock option with an expiration date of July 21, 2023. Equity Components [Axis] Equity Component [Domain] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) Employee Stock Option, Expiration Date of January 29, 2024 [Member] Represents stock option with an expiration date of January 29, 2024. Class of Warrant or Right [Axis] Employee Stock Option, Expiration Date of June10, 2024 [Member] Represents stock option with an expiration date of June 10, 2024. Class of Warrant or Right [Domain] us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) Employee Stock Option, Expiration Date of December 21, 2023 [Member] Represents stock option with an expiration date of December 21, 2023. us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) Office and administration Decrease (increase) in accounts payable and accrued expenses due to related parties Vesting Every Six Months [Member] Represents the options vested every 6 months. Cash and cash equivalents us-gaap_CashAndCashEquivalentsAtCarryingValue Stock-based compensation (Note 7) us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense Document Quarterly Report Amendment Flag Entity Incorporation, State or Country Code Accounting Policies [Abstract] Document Transition Report City Area Code Entity Interactive Data Current Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance (in shares) Current Fiscal Year End Date us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Decrease in prepaid expenses and other current assets Selling, General and Administrative Disclosure [Text Block] The entire disclosure for selling, general and administrative expenses. Document Fiscal Period Focus Document Fiscal Year Focus Schedule of Selling, General and Administrative Expenses [Table Text Block] Tabular disclosure of selling, general and administrative expenses. Document Period End Date Entity File Number Entity Emerging Growth Company Document Type Filing and regulatory fees Expenditures for filing and regulatory. Entity Small Business Entity Shell Company Document Information [Line Items] Document Information [Table] Entity Filer Category Entity Current Reporting Status Weighted average number of common shares outstanding – basic and diluted (in shares) Contingent consideration us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Share-based compensation Entity Tax Identification Number Net loss per share - basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Entity [Domain] Legal Entity [Axis] Statement [Table] Entity Address, Address Line One Statement of Financial Position [Abstract] us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Share issuance costs - cash Accounts Payable and Accrued Liabilities Disclosure [Text Block] Entity Address, City or Town Entity Address, Country Entity Address, Postal Zip Code Business Acquisition [Axis] Entity Address, State or Province Business Acquisition, Acquiree [Domain] Statement of Cash Flows [Abstract] Entity Common Stock, Shares Outstanding Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Professional fees Transaction costs Marketing Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Shares issued for asset acquisition (in shares) Local Phone Number Shares issued for asset acquisition us-gaap_TableTextBlock Notes Tables Warrants Issued in Connection With Business Acquisition [Member] Represents warrants issued in connection with business acquisition. OCL Technologies Corp [Member] Represents OCL Technologies Corp. Selling, general and administrative (Note 8) Selling, General and Administrative Expense, Total us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term (Year) Sale of common stock (in shares) Stock Issued During Period, Shares, New Issues (in shares) us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Sale of common stock Accumulated deficit Retained Earnings (Accumulated Deficit), Ending Balance Research and development us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Total Purchase Price Changes in operating assets and liabilities: us-gaap_StockholdersEquity Stockholders' equity Balance Balance ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved The percent of issued and outstanding common shares reserved in a share-based compensation. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] Class of Stock [Axis] Rolling Stock Option Plan [Member] Related to the Rolling Stock Option Plan. Cash acquired on asset acquisition us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Accounts payable and due from related party EX-101.PRE 10 ovtz-20210930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 oculusvision.jpg begin 644 oculusvision.jpg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ǦEU^%1$A(_= MW''^L)[$=QW/3KQR&@>']8\?^)G2$F269_-NKIQ\L8)Y)_H*[\+2YOWDWHCC MQ-6W[N&[-+X:>$)/%?B2-9D/]GVI$ER_8CLGU/3Z9KVKQJ_V#5O"5Q&TB1+J MJ6QCCX4AU(&?H0*VO#'AJP\*:)'INF*=BG=)(WWI7[L?RK&^)Q$/A%+TRM$+ M*^MKCF1TW-@46.MZ/I\GB/7?M.H&"WN5LY8Y7#QB2,!=L" ]RP'/4T[PE;LEG MJ'BW5E*7>J S[7./(ME!\M/;Y>3[FL#0X-$F^%D$/BZ\CLAK4\MWYCN(V#F0 ML&#=,X"G]*FRMR]K+_/\@N[\W?7_ "_,[*'Q)YFE7][J&E:AID-G#YS&Z5%+ M+M+?+M8\@#OC!K+T_P 0:9X:\&Z02^IWAOEW6<$V)KN??\^.#@X#=-RD$@C/'6LH_$O3Y+.>XL]*U6\2U:07/V>!6\@(2,L=V M!G!('7 R0 166VIKJWBG5/%MB&.E:-I4L$-SM^6XEY9BO]Y0.,^M-AC_ .$: M^ #%4*33:>6; ^8O-ZY[_./RI>SCI=:NP>TEW[DOCBQTC5_!MSXN2YO WV - M;;+DQ*,_=RH[Y;IWZ4_3]"T;P/IVG:SJ-QJ,NH&-(A#Y[2M/,Z8*K'T)Y/TI MOBK3S:>!/#?AF,V5S1X^$47C'P[/J&ISZ391QSK'>1!= ML4Q"@9W @97(SBJC=I0OIK]R%+1N5M=/O.DTOQ9:ZCJ4^GW5I=Z7>0P"Y,-\ MJJ6B/\8(8C /!]#56S\=6^IW2II&D:K?6K3>4M]# OD$YP3N+ [1ZXKF-6TW M3[KP5XCO_#.JW&O:L]LL$UV9O-;R]P9D7: H&W<<**Z[PWXD\.7>GV=CHNH6 MKE+92EO$WS(JJ.J]1CWK.4(I);E+"\U&XB6"TB@L MH-[HBJ2[$Y W8'7)].M=QH&N6GB/18=3L!(L,V1LE #H02"&&3@Y%/K6M\.;(V7P^TI9!^\FB-Q(2NTDR$OG M]13K*-GY67X!2;NO.[.GHHHKE.@**** "BBB@ HHHH **** "JVI:;9ZOITU MAJ=NES:SKMDB<<,/Z?7M5FB@#PW4OV<+:X\3QRZ?J[6^C,2TD3+NGC/95/0C MKR>1[]:]?T'P]IOAK2TL-'MEAB40_P!YFZD_6M.BG=VL*RO<*;)&DL92 M5%=&ZJPR#3J*0Q"BE-A4;<8VXXQZ5&UK;O"L3P1M&OW4* @?05+10!&8(6C6 M-HD*(054J,+CI@4LL$4Z;9XDD7.<.H(S^-/HH 9Y48A\H1KY>-NS;QCTQ0\, M4D?ER1HZ XML 12 ovtz20210930_10q_htm.xml IDEA: XBRL DOCUMENT 0001107280 2021-01-01 2021-09-30 0001107280 2021-11-09 0001107280 2021-09-30 0001107280 2020-12-31 0001107280 2021-07-01 2021-09-30 0001107280 2020-07-01 2020-09-30 0001107280 2020-01-01 2020-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2019-12-31 0001107280 us-gaap:RetainedEarningsMember 2019-12-31 0001107280 2019-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2020-01-01 2020-09-30 0001107280 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2020-09-30 0001107280 us-gaap:RetainedEarningsMember 2020-09-30 0001107280 2020-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2020-12-31 0001107280 us-gaap:RetainedEarningsMember 2020-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2021-01-01 2021-09-30 0001107280 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2021-09-30 0001107280 us-gaap:RetainedEarningsMember 2021-09-30 0001107280 2020-01-01 2020-12-31 0001107280 2019-01-01 2019-12-31 0001107280 ovtz:OCLTechnologiesCorpMember 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember 2020-01-01 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-01-01 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 2020-06-05 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 2020-06-05 0001107280 ovtz:EmployeeAndDirectorsMember 2020-06-05 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 0001107280 us-gaap:PrivatePlacementMember 2021-06-14 2021-06-14 0001107280 us-gaap:PrivatePlacementMember 2021-06-14 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-06-14 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-06-14 2021-06-14 0001107280 ovtz:RollingStockOptionPlanMember 2020-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2021-09-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2021-01-29 2021-01-29 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2021-01-29 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-01-29 2021-01-29 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-09-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-06-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-06-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-09-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-09-30 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-01-01 2021-09-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2020-07-21 2020-07-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2020-07-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2021-07-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2021-07-21 2021-07-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2020-07-21 2020-07-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-09-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-12-21 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2020-12-21 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-09-30 0001107280 ovtz:Covid19Member 2021-01-01 2021-09-30 shares iso4217:USD iso4217:USD shares pure utr:Y iso4217:CAD shares iso4217:CAD utr:M 0001107280 OCULUS VISIONTECH INC. false --12-31 Q3 2021 0 0 250000000 250000000 0 0 0 0 500000000 500000000 91422569 91422569 86522569 86522569 -0.01 12500000 P5Y 0 0 500000000 0.80 3920000 1.00 2.50 45500 0.10 1.20 424300 1.25 0.0014 0 230604 0.80 211700 1.2080 0.0025 0 0.8000 59248 0.35 909900 1.25 0.0027 0 0.35 369597 334385 0.45 75800 1.25 0.0002 0 1899 43439 10-Q true 2021-09-30 false 0-29651 WY 06-1576391 Suite 507 - 837 West Hastings Street Vancouver BC CA V6C 3N6 604 685-1017 Yes Yes Non-accelerated Filer true false false 91422569 2706660 490190 9482 6082 2716142 496272 109084 32329 135759 135738 244843 168067 47672522 44073257 414128 414128 -45615351 -44159180 2471299 328205 2716142 496272 0 0 0 0 0 0 24021 0 295830 93270 575999 130180 113607 83605 319132 204447 169373 120098 537019 120098 578810 296973 1456171 454725 -578810 -296973 -1456171 -454725 0 0 0 96 0 0 0 96 -578810 -296973 -1456171 -454629 -0.00 -0.02 -0.01 91422569 86522569 89476981 78165426 67022568 41634999 0 -41386696 248303 7000001 773038 0 0 773038 12500000 1380427 0 0 1380427 0 414128 0 414128 120098 0 0 120098 0 0 -454629 -454629 86522569 43908562 414128 -41841325 2481365 86522569 44073257 414128 -44159180 328205 4900000 3098616 0 0 3098616 36370 -0 -0 36370 537019 0 0 537019 0 0 -1456171 -1456171 91422569 47672522 414128 -45615351 2471299 -1456171 -454629 537019 120098 3400 3419 76755 -241373 21 5499 -845776 -573824 0 114169 0 114169 3098616 773038 36370 -0 3062246 773038 2216470 313383 490190 382452 2706660 695835 0 0 0 0 0 1380427 -0 1966939 0 414128 0 172384 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>BASIS OF PRESENTATION AND BUSINESS</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended <em style="font: inherit;"> December 31, 2020. </em>These unaudited condensed interim consolidated financial statements do <em style="font: inherit;">not</em> include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended <em style="font: inherit;"> December 31, 2020, </em>except when disclosed below.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, ComplyTrust® Inc. (formerly OCL Technologies Corp.) (from the date of acquisition, Note <em style="font: inherit;">5</em>). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company’s annual report on Form <em style="font: inherit;">10</em>-K for the fiscal year ended <em style="font: inherit;"> December 31, 2020.</em></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Oculus VisionTech, Inc. (the "<i>Company</i>") is a designer of digital watermarking services and solutions. At <em style="font: inherit;"> September 30, 2021 </em>and fiscal <em style="font: inherit;">2020,</em> substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>GOING CONCERN </b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of $1,456,171 for the <em style="font: inherit;">nine</em> month period ended <em style="font: inherit;"> September 30, 2021 </em>and, in addition the Company incurred losses of $2,772,484 and $192,865 for the year ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;">2019.</em> As of <em style="font: inherit;"> September 30, 2021, </em>the Company had an accumulated deficit of $45,615,351 and a working capital of $2,471,299. These conditions raise doubt about the Company’s ability to continue as a going concern.  The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  The financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.</p> -1456171 -2772484 -192865 -45615351 2471299 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">3.</em></b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>PREPAID EXPENSES AND OTHER CURRENT ASSETS</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses and other current assets consist of the following:</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">September 30,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Prepaid expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,403</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,030</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Tax Receivable – Canadian GST</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,079</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,052</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,482</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,082</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">September 30,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Prepaid expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,403</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,030</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Tax Receivable – Canadian GST</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,079</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,052</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,482</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,082</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> </tbody></table> 2403 1030 7079 5052 9482 6082 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">4.</em></b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable and accrued expenses consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">September 30,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">60,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">16,670</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued fees and expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">49,084</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15,659</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">109,084</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">32,329</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable and accrued expenses – related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.</p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">September 30,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">60,000</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">16,670</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued fees and expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">49,084</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15,659</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">109,084</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">32,329</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 60000 16670 49084 15659 109084 32329 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">5.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ACQUISITION OF COMPLYTRUST INC. (FORMERLY OCL TECHNOLOGIES CORP.)</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company acquired a 100% interest in ComplyTrust Inc. (formerly OCL Technologies Corp.) (“CTI”) by issuing 12,500,000 shares with a fair value of $1,380,427 and contingent consideration consisting of 12,500,000 non-transferable warrants with a fair value of $414,128. The transaction does <em style="font: inherit;">not</em> meet the definition of a business as defined in ASC <em style="font: inherit;">805</em>-<em style="font: inherit;">10.</em> As a result, the acquisition of CTI has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, CTI became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Issuance of <span style="-sec-ix-hidden:c78447128">12,500,000</span> shares</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,380,427</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration – warrants</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">414,128</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">54,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,849,087</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of <span style="-sec-ix-hidden:c78447023">five</span> years from the date of issuance expiry <em style="font: inherit;"> June 4, 2025. </em><em style="font: inherit;">No</em> share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being <em style="font: inherit;">1</em>) revenue sales projections per CTI’s <em style="font: inherit;">5</em> year proformas, or <em style="font: inherit;">2</em>) listing on a major US exchange, or <em style="font: inherit;">3</em>) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">114,169</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(232,021</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,966,939</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,849,087</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of $1,966,939.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 1 12500000 1380427 12500000 414128 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Issuance of <span style="-sec-ix-hidden:c78447128">12,500,000</span> shares</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,380,427</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration – warrants</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">414,128</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">54,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,849,087</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 1380427 414128 54532 1849087 12500000 12500000 0.001 414128 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">114,169</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(232,021</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,966,939</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,849,087</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 114169 232021 1966939 1849087 1966939 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">6.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COMMON STOCK</b> </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company has <em style="font: inherit;">one</em> class of <span style="-sec-ix-hidden:c78447034"><span style="-sec-ix-hidden:c78447129">no</span></span> par value common stock with <span style="-sec-ix-hidden:c78447035">500,000,000</span> authorized shares 91,422,569 and 86,522,569 outstanding on <em style="font: inherit;"> September 30, 2021 </em>and <em style="font: inherit;"> December 31, 2020, </em>respectively.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> June 5, 2020, </em>the Company issued 12,500,000 shares at a value of $0.15 CDN per share pursuant to the acquisition of OCL Technologies Corp.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> June 5, 2020, </em>the Company issued 7,000,001 shares to investors, including 1,766,667 common shares to a consultant and directors at $0.15 CDN per share.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On <em style="font: inherit;"> June 14, 2021, </em>the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of <span style="-sec-ix-hidden:c78447044">CDN$0.80</span> per unit for gross proceeds of <span style="-sec-ix-hidden:c78447045">$3,920,000CDN</span> ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of <span style="-sec-ix-hidden:c78447050">$1.00CDN</span> for a period of 24 months from the date of closing. The expiry date of the warrants <em style="font: inherit;"> may </em>be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than <span style="-sec-ix-hidden:c78447052">$2.50CDN</span> for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid <span style="-sec-ix-hidden:c78447054">$45,500CDN</span> ($36,370) as share issuance costs.</p> 500000000 91422569 86522569 12500000 0.15 7000001 1766667 0.15 4900000 3098616 1 1 1 P24M 10 36370 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">7.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>STOCK OPTIONS</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the period ended <em style="font: inherit;"> September 30, 2021 </em>and year ended <em style="font: inherit;"> December 31, 2020, </em>the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares <em style="font: inherit;"> may </em>be reserved for granting of stock options.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company:</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of <span style="-sec-ix-hidden:c78447060">$1.20CDN</span> and an expiry date of <em style="font: inherit;"> January 29, 2024. </em>The options have a fair value of <span style="-sec-ix-hidden:c78447061">$424,300CDN,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c78447062">125%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c78447064">0.14%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c78447065">Nil;</span> and (v) market stock price of $1.18. The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> July 29, 2021. </em>During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c78447069">$230,604CND</span> ($186,627) of stock-based compensation relating to the vesting period.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">i) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of <span style="-sec-ix-hidden:c78447073">$0.80CDN</span> and an expiry date of <em style="font: inherit;"> June 10, 2024. </em>The options have a fair value of <span style="-sec-ix-hidden:c78447074">$211,700CDN,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c78447075">120.80%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c78447077">0.25%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c78447078">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c78447079">$0.8000CDN.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> December 10, 2021. </em>During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c78447082">$59,248CDN</span> ($48,592) of stock-based compensation relating to the vesting period.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company:</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of <span style="-sec-ix-hidden:c78447086">$0.35CDN</span> and an expiry date of <em style="font: inherit;"> July 21, 2023. </em>The options have a fair value of <span style="-sec-ix-hidden:c78447087">$909,900CDN,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c78447088">125%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c78447090">0.27%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c78447091">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c78447092">$0.35.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> January 21, 2020. </em>During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company recorded <span style="-sec-ix-hidden:c78447095">$369,597CDN</span> ($283,307) of stock-based compensation relating to the vesting period. During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c78447097">$334,385CDN</span> ($267,221) of stock-based compensation relating to the vesting period.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of <span style="-sec-ix-hidden:c78447101">$0.45CDN</span> and an expiry date of <em style="font: inherit;"> December 21, 2023. </em>The options have a fair value of <span style="-sec-ix-hidden:c78447102">$75,800CDN,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c78447103">125%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c78447105">0.02%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c78447106">Nil;</span> and (v) market stock price of $0.425. The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> June 21, 2021. </em>During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company recorded <span style="-sec-ix-hidden:c78447110">$1,899CDN</span> ($1,486) of stock-based compensation relating to the vesting period. During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c78447112">$43,439CDN</span> ($34,579) of stock-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 0.10 500000 500000 P3Y 1.18 0.20 186627 375000 375000 P3Y 0.20 48592 3600000 3600000 P3Y 0.20 283307 267221 250000 250000 P3Y 0.425 0.20 1486 34579 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">8.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SELLING, GENERAL</b> <b>AND ADMINISTRATIVE</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The breakdown of selling, general and administrative for the period ended <em style="font: inherit;"> September 30, 2021 </em>as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 15%; width: 85%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 82%; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 82%; border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Filing and regulatory fees</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-top: 1px solid rgb(0, 0, 0);">26,731</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Marketing</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">31,374</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Professional fees</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">102,870</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Rent</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">29,857</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Office and administration</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">128,300</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">319,132</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 15%; width: 85%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 82%; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-top: 3px double black;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 82%; border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Filing and regulatory fees</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 1px solid rgb(0, 0, 0);">$</td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-top: 1px solid rgb(0, 0, 0);">26,731</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Marketing</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">31,374</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Professional fees</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">102,870</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Rent</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">29,857</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Office and administration</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">128,300</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">319,132</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 26731 31374 102870 29857 128300 319132 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">9.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COVID-<em style="font: inherit;">19</em></b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In early <em style="font: inherit;">2020,</em> a coronavirus that causes COVID-<em style="font: inherit;">19</em> emerged globally, which is currently affecting the global economies and has a resulting effect on the Company.  Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.</p> XML 13 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2021
Nov. 09, 2021
Document Information [Line Items]    
Entity Central Index Key 0001107280  
Entity Registrant Name OCULUS VISIONTECH INC.  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2021  
Document Transition Report false  
Entity File Number 0-29651  
Entity Incorporation, State or Country Code WY  
Entity Tax Identification Number 06-1576391  
Entity Address, Address Line One Suite 507 - 837 West Hastings Street  
Entity Address, City or Town Vancouver  
Entity Address, State or Province BC  
Entity Address, Country CA  
Entity Address, Postal Zip Code V6C 3N6  
City Area Code 604  
Local Phone Number 685-1017  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   91,422,569
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
ASSETS    
Cash and cash equivalents $ 2,706,660 $ 490,190
Prepaid expenses and other current assets 9,482 6,082
Total Assets 2,716,142 496,272
Current Liabilities:    
Accounts payable and accrued expenses 109,084 32,329
Accounts payable and accrued expenses - related parties 135,759 135,738
Total current liabilities 244,843 168,067
Commitments and Contingencies
Stockholders' Equity:    
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 86,522,569 47,672,522 44,073,257
Commitment to issue shares 414,128 414,128
Accumulated deficit (45,615,351) (44,159,180)
Stockholders' equity 2,471,299 328,205
Total Liabilities and Stockholders' Equity $ 2,716,142 $ 496,272
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
$ / shares in Thousands
Sep. 30, 2021
Dec. 31, 2020
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 250,000,000 250,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 91,422,569 86,522,569
Common stock, shares outstanding (in shares) 91,422,569 86,522,569
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue $ 0 $ 0 $ 0 $ 0
Expenses:        
Consulting 0 0 24,021 0
Research and development 295,830 93,270 575,999 130,180
Selling, general and administrative (Note 8) 113,607 83,605 319,132 204,447
Stock-based compensation (Note 7) 169,373 120,098 537,019 120,098
Total expenses 578,810 296,973 1,456,171 454,725
Loss from operations (578,810) (296,973) (1,456,171) (454,725)
Other income        
Interest income 0 0 0 96
Nonoperating Income (Expense), Total 0 0 0 96
Net loss $ (578,810) $ (296,973) $ (1,456,171) $ (454,629)
Net loss per share - basic and diluted (in dollars per share) $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Weighted average number of common shares outstanding – basic and diluted (in shares) 91,422,569 86,522,569 89,476,981 78,165,426
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock Including Additional Paid in Capital [Member]
Commitment to Issue Shares [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 67,022,568      
Balance at Dec. 31, 2019 $ 41,634,999 $ 0 $ (41,386,696) $ 248,303
Sale of common stock (in shares) 7,000,001      
Sale of common stock $ 773,038 0 0 773,038
Shares issued for asset acquisition (in shares) 12,500,000      
Shares issued for asset acquisition $ 1,380,427 0 0 1,380,427
Contingent consideration 0 414,128 0 414,128
Share-based compensation 120,098 0 0 120,098
Net loss $ 0 0 (454,629) (454,629)
Balance (in shares) at Sep. 30, 2020 86,522,569      
Balance at Sep. 30, 2020 $ 43,908,562 414,128 (41,841,325) 2,481,365
Balance (in shares) at Dec. 31, 2019 67,022,568      
Balance at Dec. 31, 2019 $ 41,634,999 0 (41,386,696) 248,303
Net loss       (2,772,484)
Balance (in shares) at Dec. 31, 2020 86,522,569      
Balance at Dec. 31, 2020 $ 44,073,257 414,128 (44,159,180) 328,205
Sale of common stock (in shares) 4,900,000      
Sale of common stock $ 3,098,616 0 0 3,098,616
Share-based compensation 537,019 0 0 537,019
Net loss 0 0 (1,456,171) (1,456,171)
Share issuance costs - cash $ (36,370) 0 0 (36,370)
Balance (in shares) at Sep. 30, 2021 91,422,569      
Balance at Sep. 30, 2021 $ 47,672,522 $ 414,128 $ (45,615,351) $ 2,471,299
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Net loss $ (578,810) $ (296,973) $ (1,456,171) $ (454,629) $ (2,772,484) $ (192,865)
Add back non-cash share-based compensation     537,019 120,098    
Changes in operating assets and liabilities:            
Decrease in prepaid expenses and other current assets     (3,400) (3,419)    
Decrease (increase) in accounts payable and accrued expenses     76,755 (241,373)    
Decrease (increase) in accounts payable and accrued expenses due to related parties     21 5,499    
Net cash used in operating activities     (845,776) (573,824)    
Cash flows from operating activities:            
Cash acquired on asset acquisition     0 114,169    
Net cash provided by investing activities     0 114,169    
Proceeds from sale of common stock     3,098,616 773,038    
Share issuance costs     (36,370) 0    
Net cash provided by financing activities     3,062,246 773,038    
Net decrease in cash and cash equivalents     2,216,470 313,383    
Cash and cash equivalents at beginning of period     490,190 382,452 382,452  
Cash and cash equivalents at end of period $ 2,706,660 $ 695,835 2,706,660 695,835 $ 490,190 $ 382,452
Supplemental disclosures of cash flow information:            
Cash paid during the period for interest     0 0    
Cash paid during the period for income taxes     0 0    
Non-cash financing and investing activities            
Common stock issued on acquisition     0 1,380,427    
Intangible acquired on acquisition     $ 0 $ (1,966,939)    
Warrants issued on acquisition (in shares)     0 414,128    
Account payable acquired on acquisition     $ 0 $ 172,384    
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Note 1 - Basis of Presentation and Business
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1.

BASIS OF PRESENTATION AND BUSINESS

 

These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended December 31, 2020. These unaudited condensed interim consolidated financial statements do not include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended December 31, 2020, except when disclosed below.

 

The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, ComplyTrust® Inc. (formerly OCL Technologies Corp.) (from the date of acquisition, Note 5). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are not necessarily indicative of the results that may be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2020.

 

Oculus VisionTech, Inc. (the "Company") is a designer of digital watermarking services and solutions. At September 30, 2021 and fiscal 2020, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Note 2 - Going Concern
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]

2.

GOING CONCERN

 

The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of $1,456,171 for the nine month period ended September 30, 2021 and, in addition the Company incurred losses of $2,772,484 and $192,865 for the year ended December 31, 2020 and 2019. As of September 30, 2021, the Company had an accumulated deficit of $45,615,351 and a working capital of $2,471,299. These conditions raise doubt about the Company’s ability to continue as a going concern.  The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Note 3 - Prepaid Expenses and Other Current Assets
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Other Assets Disclosure [Text Block]

3.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

  

September 30,

2021

  

December 31,

2020

 
         

Prepaid expenses

 $2,403  $1,030 

Tax Receivable – Canadian GST

  7,079   5,052 
  $9,482  $6,082 

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Note 4 - Accounts Payable and Accrued Expenses
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

4.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

  

September 30,

2021

  

December 31,

2020

 
         

Accounts payable

 $60,000  $16,670 

Accrued fees and expenses

  49,084   15,659 
  $109,084  $32,329 

 

Accounts payable and accrued expenses – related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.)
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Mergers, Acquisitions and Dispositions Disclosures [Text Block]

5.

ACQUISITION OF COMPLYTRUST INC. (FORMERLY OCL TECHNOLOGIES CORP.)

 

During the year ended December 31, 2020, the Company acquired a 100% interest in ComplyTrust Inc. (formerly OCL Technologies Corp.) (“CTI”) by issuing 12,500,000 shares with a fair value of $1,380,427 and contingent consideration consisting of 12,500,000 non-transferable warrants with a fair value of $414,128. The transaction does not meet the definition of a business as defined in ASC 805-10. As a result, the acquisition of CTI has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, CTI became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:

 

     

Purchase Price

    
     

Issuance of 12,500,000 shares

 $1,380,427 

Contingent consideration – warrants

  414,128 

Transaction costs

  54,532 
     

Total Purchase Price

 $1,849,087 

 

Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five years from the date of issuance expiry June 4, 2025. No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per CTI’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.

 

     

Purchase Price Allocation

    
     

Cash

 $114,169 

Accounts payable and due from related party

  (232,021

)

Intangible asset

  1,966,939 
     

Total Purchase Price

 $1,849,087 

 

During the year ended December 31, 2020, the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of $1,966,939.

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Note 6 - Common Stock
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

6.

COMMON STOCK 

 

The Company has one class of no par value common stock with 500,000,000 authorized shares 91,422,569 and 86,522,569 outstanding on September 30, 2021 and December 31, 2020, respectively.

 

On June 5, 2020, the Company issued 12,500,000 shares at a value of $0.15 CDN per share pursuant to the acquisition of OCL Technologies Corp.

 

On June 5, 2020, the Company issued 7,000,001 shares to investors, including 1,766,667 common shares to a consultant and directors at $0.15 CDN per share.

 

On June 14, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of $3,920,000CDN ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of $1.00CDN for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than $2.50CDN for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid $45,500CDN ($36,370) as share issuance costs.

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Note 7 - Stock Options
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

7.

STOCK OPTIONS  

 

During the period ended September 30, 2021 and year ended December 31, 2020, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options.

 

During the period ended September 30, 2021, the Company:

 

i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CDN and an expiry date of January 29, 2024. The options have a fair value of $424,300CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.14%; (iv) Dividend rate of Nil; and (v) market stock price of $1.18. The options vest 20% every 6 months starting July 29, 2021. During the period ended September 30, 2021, the Company recorded $230,604CND ($186,627) of stock-based compensation relating to the vesting period.

 

i) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of $0.80CDN and an expiry date of June 10, 2024. The options have a fair value of $211,700CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 120.80%; (ii) Term of 3 years; (iii) Discount rate of 0.25%; (iv) Dividend rate of Nil; and (v) market stock price of $0.8000CDN. The options vest 20% every 6 months starting December 10, 2021. During the period ended September 30, 2021, the Company recorded $59,248CDN ($48,592) of stock-based compensation relating to the vesting period.

 

During the year ended December 31, 2020, the Company:

 

i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CDN and an expiry date of July 21, 2023. The options have a fair value of $909,900CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35. The options vest 20% every 6 months starting January 21, 2020. During the year ended December 31, 2020, the Company recorded $369,597CDN ($283,307) of stock-based compensation relating to the vesting period. During the period ended September 30, 2021, the Company recorded $334,385CDN ($267,221) of stock-based compensation relating to the vesting period.

 

ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CDN and an expiry date of December 21, 2023. The options have a fair value of $75,800CDN, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.02%; (iv) Dividend rate of Nil; and (v) market stock price of $0.425. The options vest 20% every 6 months starting June 21, 2021. During the year ended December 31, 2020, the Company recorded $1,899CDN ($1,486) of stock-based compensation relating to the vesting period. During the period ended September 30, 2021, the Company recorded $43,439CDN ($34,579) of stock-based compensation relating to the vesting period.

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Note 8 - Selling, General and Administrative
9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Selling, General and Administrative Disclosure [Text Block]

8.

SELLING, GENERAL AND ADMINISTRATIVE

 

The breakdown of selling, general and administrative for the period ended September 30, 2021 as follows:

 

     

Filing and regulatory fees

 $26,731 

Marketing

  31,374 

Professional fees

  102,870 

Rent

  29,857 

Office and administration

  128,300 
     
  $319,132 

 

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Note 9 - COVID-19
9 Months Ended
Sep. 30, 2021
COVID-19 [Member]  
Notes to Financial Statements  
Unusual or Infrequent Items, or Both, Disclosure [Text Block]

9.

COVID-19  

 

In early 2020, a coronavirus that causes COVID-19 emerged globally, which is currently affecting the global economies and has a resulting effect on the Company.  Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Note 3 - Prepaid Expenses and Other Current Assets (Tables)
9 Months Ended
Sep. 30, 2021
Notes Tables  
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
  

September 30,

2021

  

December 31,

2020

 
         

Prepaid expenses

 $2,403  $1,030 

Tax Receivable – Canadian GST

  7,079   5,052 
  $9,482  $6,082 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Note 4 - Accounts Payable and Accrued Expenses (Tables)
9 Months Ended
Sep. 30, 2021
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
  

September 30,

2021

  

December 31,

2020

 
         

Accounts payable

 $60,000  $16,670 

Accrued fees and expenses

  49,084   15,659 
  $109,084  $32,329 
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables)
9 Months Ended
Sep. 30, 2021
Notes Tables  
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
     

Purchase Price

    
     

Issuance of 12,500,000 shares

 $1,380,427 

Contingent consideration – warrants

  414,128 

Transaction costs

  54,532 
     

Total Purchase Price

 $1,849,087 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
     

Purchase Price Allocation

    
     

Cash

 $114,169 

Accounts payable and due from related party

  (232,021

)

Intangible asset

  1,966,939 
     

Total Purchase Price

 $1,849,087 
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Note 8 - Selling, General and Administrative (Tables)
9 Months Ended
Sep. 30, 2021
Notes Tables  
Schedule of Selling, General and Administrative Expenses [Table Text Block]
     

Filing and regulatory fees

 $26,731 

Marketing

  31,374 

Professional fees

  102,870 

Rent

  29,857 

Office and administration

  128,300 
     
  $319,132 
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Note 2 - Going Concern (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Net Income (Loss) Attributable to Parent, Total $ (578,810) $ (296,973) $ (1,456,171) $ (454,629) $ (2,772,484) $ (192,865)
Retained Earnings (Accumulated Deficit), Ending Balance (45,615,351)   (45,615,351)   $ (44,159,180)  
Working Capital (Deficit) $ 2,471,299   $ 2,471,299      
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Prepaid expenses $ 2,403 $ 1,030
Tax Receivable – Canadian GST 7,079 5,052
Prepaid Expense and Other Assets, Current $ 9,482 $ 6,082
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Accounts payable $ 60,000 $ 16,670
Accrued fees and expenses 49,084 15,659
Accounts Payable and Accrued Liabilities, Current, Total $ 109,084 $ 32,329
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 0 $ 1,380,427  
Warrants and Rights Outstanding $ 414,128   $ 414,128
Impairment of Intangible Assets (Excluding Goodwill), Total     $ 1,966,939
OCL Technologies Corp [Member]      
Business Acquisition, Percentage of Voting Interests Acquired     100.00%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)     12,500,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable     $ 1,380,427
Warrants and Rights Outstanding     414,128
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]      
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable     $ 414,128
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)     12,500,000
Warrants and Rights Outstanding     $ 414,128
Class of Warrant or Right, Outstanding (in shares)     12,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)     $ 0.001
Warrants and Rights Outstanding, Term (Year)     5 years
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Common stock issued on acquisition $ 0 $ 1,380,427  
OCL Technologies Corp [Member]      
Common stock issued on acquisition     $ 1,380,427
Transaction costs     54,532
Total Purchase Price     1,849,087
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]      
Common stock issued on acquisition     $ 414,128
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals)
12 Months Ended
Dec. 31, 2020
shares
OCL Technologies Corp [Member]  
Shares issued (in shares) 12,500,000
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details) - OCL Technologies Corp [Member]
Dec. 31, 2020
USD ($)
Cash $ 114,169
Accounts payable and due from related party (232,021)
Intangible asset 1,966,939
Total Purchase Price $ 1,849,087
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Note 6 - Common Stock (Details Textual)
$ / shares in Units, $ / shares in Thousands
9 Months Ended
Jun. 14, 2021
USD ($)
shares
Jun. 14, 2021
CAD ($)
$ / shares
shares
Jun. 05, 2020
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
$ / shares
shares
Common Stock, No Par Value (in dollars per share) | $ / shares       $ 0   $ 0
Common Stock, Shares Authorized (in shares)       500,000,000   500,000,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)       91,422,569   86,522,569
Payments of Stock Issuance Costs | $       $ 36,370 $ (0)  
Warrants Issued in Connection with Private Placement [Member]            
Equity Offering, Number of Warrants Per Unit (in shares)   1        
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)   1        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares   $ 1.00        
Warrants and Rights Outstanding, Term (Year)   24 months        
Class of Warrant of Right, Stock Price Trigger (in CAD per share) | $ / shares   $ 2.50        
Class of Warrant or Right, Threshold Consecutive Trading Days 10 10        
Payments of Stock Issuance Costs | $ $ 36,370          
Private Placement [Member]            
Equity Offering, Number of Units Issued (in shares) 4,900,000 4,900,000        
Equity Offering, Price Per Unit Issued (in CAD per share) | $ / shares   $ 0.80        
Proceeds from Issuance or Sale of Equity, Total $ 3,098,616 $ 3,920,000        
Equity Offering, Number of Common Shares Per Unit (in shares)   1        
Payments of Stock Issuance Costs | $   $ 45,500        
OCL Technologies Corp [Member]            
Stock Issued During Period, Shares, New Issues (in shares)     12,500,000      
Shares Issued, Price Per Share (in CAD per share) | $ / shares     $ 0.15      
Investors [Member]            
Stock Issued During Period, Shares, New Issues (in shares)     7,000,001      
Shares Issued, Price Per Share (in CAD per share) | $ / shares     $ 0.15      
Employee and Directors [Member]            
Stock Issued During Period, Shares, New Issues (in shares)     1,766,667      
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Note 7 - Stock Options (Details Textual)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 21, 2021
CAD ($)
$ / shares
Jan. 29, 2021
CAD ($)
$ / shares
shares
Dec. 21, 2020
CAD ($)
$ / shares
shares
Jul. 21, 2020
$ / shares
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2021
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2021
CAD ($)
$ / shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CAD ($)
Share-based Payment Arrangement, Expense | $         $ 169,373 $ 120,098   $ 537,019   $ 120,098    
Rolling Stock Option Plan [Member]                        
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved                 10.00%   10.00% 10.00%
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares   500,000                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares   500,000                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares   $ 1.20                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $   $ 424,300                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   125.00%                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)   3 years                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions   0.14%                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares   $ 1.18                    
Share-based Payment Arrangement, Expense               $ 186,627 $ 230,604      
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member] | Vesting Every Six Months [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   20.00%                    
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of June10, 2024 [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares             375,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares             375,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares                 $ 0.80      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $                 $ 211,700      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate               120.80% 120.80%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)               3 years 3 years      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions               0.25% 0.25%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate               0.00% 0.00%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares                 $ 0.8000      
Share-based Payment Arrangement, Expense               $ 48,592 $ 59,248      
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | Vesting Every Six Months [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage               20.00% 20.00%      
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of July 21, 2023 [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares       3,600,000                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares       3,600,000                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares $ 0.35                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $ $ 909,900                      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate       125.00%                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)       3 years                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions       0.27%                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate       0.00%                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares       $ 0.35                
Share-based Payment Arrangement, Expense               $ 267,221 $ 334,385   $ 283,307 $ 369,597
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of July 21, 2023 [Member] | Vesting Every Six Months [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage       20.00%                
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of December 21, 2023 [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares     250,000                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares     250,000                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares     $ 0.45                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $     $ 75,800                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     125.00%                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)     3 years                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions     0.02%                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00%                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares     $ 0.425                  
Share-based Payment Arrangement, Expense               $ 34,579 $ 43,439   $ 1,486 $ 1,899
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of December 21, 2023 [Member] | Vesting Every Six Months [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     20.00%                  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Filing and regulatory fees     $ 26,731  
Marketing     31,374  
Professional fees     102,870  
Rent     29,857  
Office and administration     128,300  
Selling, General and Administrative Expense, Total $ 113,607 $ 83,605 $ 319,132 $ 204,447
EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,U+:5,'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #-2VE3I^-#->T K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)O)VE%,'1[43PI""XHWD(RNQML_I",M/OVIG6WB^@#>,S,+]]\ M ]/I*'5(^)Q"Q$06\]7D!I^ECAMV((H2(.L#.I7KDO"EN0O)*2K/M(>H](?: M(S2GQ95FWLCZ3 M\AK+KVPE'2-NV'GR:WMWOWU@?<,;40E1\=NMN)8MEZ)]GUU_^%V$73!V9_^Q M\5FP[^#77?1?4$L#!!0 ( ,U+:5.97)PC$ 8 )PG 3 >&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ MS4MI4TY'X?OX! 5Q0 !@ !X;"]W;W)K>:O*1)IBYZ6ZUWGQQ'A5N>,G4F=CR# M;]9"IDS#I=PX:B[=R-A6Y3N*,WTJB\C1E\O62 M)V)_T?-ZAQL_XLU6FQO.;+IC&[[B^GYW*^'*J52B..69BD5&)%]?].;>I\!W M38!]XB'F>W7TF9A7>1+BE[E81!<]UQ#QA(?:2##X]\P#GB1&"3C^*45[U9@F M\/CS0?W*OCR\S!-3/!#)8QSI[47OO$OM#0Z(4B4?8OV1?/ M#@8]$N9*B[0,!H(TSHK_[*5,Q%& /SX10,L ^B[ .S6"7P;X]D4+,OM:GYEF MLZD4>R+-TZ!F/MC<_O?,9 CE_:Z@7S/F=1<)F;U[834C5"XEI8Y-K<]6D/1;E#E M],%F=HO4P=M_^_"AK7BU/WM^Q^*!1:G8^C.2-%RLS1&\VM*]3IY^%2><+//T MBXRQL MSBRN>1E@&]*Z/U#RN9RLRS(-;1$;G MP[[G>F.,J.X*M-M.O]PP%GT*EKF=[8-M1_.@V M39X=4!O)<,46LKHGT$X]P712:%-@"AMQ8NWA.DN1]5D8%J=8Q846.WL0]"2T%JG]N.4LXM(\ -^O MA="'"S- =98X^Q=02P,$% @ S4MI4SN^[N8R! ?PT !@ !X;"]W M;W)KJ MK-7%K[SQXTV"]/%K*&/;,WT7;.2,)OV M5@I>L5IQ42/)'N;>-;Y:XM@H6(E_.-NJ@S$R5.Z%>#*3;\7<\PTB5K)<&Q,4 M'L]LRT)+6.4-KLX%"GY:ME*S6: 6BHD!W-6T+#H*?T06Z6]^B M3[]]GDTUX#+6I_D.PTV'@9S!L&;-)0K\"2(^P0[UY;CZ+4RT6= MJ=B:,G?O>4$2/XYC8/1\Z(NA7)CY.-N+'4$->ZCA*-259 WE!6(OC8D&96$+ MO6$2@K [XAT*Q?R!TA#KJ44>CJ'\(34MT?198--B3 M)#C&X2FVH5R8Q20Y@R[NT<6CV0/$C13[^\SNCZ\?F1U?@;ON#W34%RIAN9L[D'' MH)A\9MX".?/UKQLZYGQ0S?#HG5MKD3]M1%DPJ7Y'7R#EZM>Q2X?W10&3=[T) M;80YYON(F/"U0+$\((\GW+_D"TU1LA^7\0V)'O M3_SNA]2& OT)XDJ9:V!3;JN5A@&<$\KP)"1D$L69?97&DZB;.L^.#'-8$B<$ M5$["S249^DE HG,1MZ]W^)V"UT< 0D_04\+MRQW#W-0^/ M%SU(2FW5=@D'.C^><^W$.2Q=%V$4XRB(\"E4EVB(HPRG9PHTWM?W,M_@=02P,$% @ S4MI4URC[DJ_ @ TP@ !@ !X M;"]W;W)KS,=J#;K^]Q$B("A<+&!?CCO,?/>VSBC-9*OY@4T<)K M)J09>ZFU^:WOFSC%C)EKE:.DF872&;/4U4O?Y!I94HHRX8=!T/(,'[7.;UF22?<;F^R?RV]DY=G9G"JQ"^>V'3L#3U(<,$*81_5^AO6?B*7 M+U;"E-^PKF,##^+"6)758B+(N*Q^V6M=ARU!IW= $-:"\%1!MQ9T2Z,566GK MGEDV&6FU!NVB*9MKE+4IU>2&2[>+C0X=4D@1HI^*7*Y *$R4$ MTP9RU%4%+M\S7:W2+U=Q?[S5A.A6V[Z.1;30NPUZ]SST>G]885.E^5^:"H 8Z. D]5 MEM'3Z_].2_3A:3D6T>+N-]S],[C//BK]O3IN]G^7_)3(EH-!XV!POH/3SLE@ MC^FFTPO#J'^S [\?..Q'[< 6^[!A'Y[/3G>RL?04Y7+YD8'AJ0;V P\8\+>N M''?=?V=ZR:4!@0N2!M<#RJ&K*[3J6)67M]"SLG2GEFGW[F@0 *,1 8 >&PO=V]R:W-H M965T&ULI5C;;N,V$/T5PBV*!$AB47>ECH%-[*(!NKM!W'2? M&8NVA4BD2])V^O<=4HIL2Y04M"^61)\9\AQQ.#.:'+AXDQM*%7HOQ'LNMH"0U1D4^=ATG'!F$ M[U2>,?HDD-P5!1'_W-.<'^Y&>/0Q\)RM-TH/C*>3+5G3!54OVR:T^PCK\KIZ-Z3FUX>O_A_3=#'LB\$DD?>/XC2]7F;A2/4$I79)>K9W[X MG5:$ NUOR7-I?M&APCHCM-Q)Q8O*&%909*R\DO=*B!,#\&,W<"L#MVG@=QAX ME8'WV1G\RL#_[ Q!96"HCTON1K@9460Z$?R A$:#-WUCU#?6H%?&]$99* '_ M9F"GI@^<29YG*5$T10L%%]@%2B*^0M^W5!#]-B6Z>&%DEV: N437Z&4Q0Q<_ M7T[&"A:@W8R7U63WY61NQV0>^LJ9VD@T9RE-+?:S?ONDQWX,Q&OV[@?[>[?7 MX8)N;Y#G7"'7<;%E/0^?-W=L=/[?[//_//N9&%Z]%3SCS^_P]TSWE.VH[;66 MAJ$QU$?/?@H3[D^%&D3,!A'S/L09([]FY!L3KX/1_!W.4TGE;8\Z0>TKZ%5' M!PH@081LS;"]H35E<,SEACU)X83-I-+'WIZBBV]<411;#[JHO2KLA4[44*(-BP$5-)1H MHSR<8,]M*-&&N8[O^Y%=B;A6(NY70O'EV[5.MBE:\D)'C#GU*_J1E7[)U@K>F MU@&LK;QO0RMP&M'.W(7O9GY0[N#(1,^ M5M;>,.M!R&P8,K= .ED?*P?L][.&'BV'2+$R\UN%2D=D6(#VR+ .R+#@H3( M"-VD@_&QOL']!R]0 MSA>=+M6Y<7!3I&"P=.SPU,R/@Q.>*W,LD'!_A?3#=)O G>PA#M84L5WQ"M2A M1X)H*"!5&A&@:=HIJ4 L'2F__!2[&/_:H6!I8)?-4CUAWW6#,&DJUT;&86!! MSFS(Q(_")&[MKS8RBG$8^&XSI,8G36=!Q=IT^Q(4V3%5-AWU:/U%X8OIHQOC M]_CV 5O&9_H+A&ERC^[+SQ=?B5AGT);F= 53.3<1+%>47P3*!\6WIN5]Y0H: M:'.[H22E0@/@_Q6'TJ9ZT!/4WV6F_P)02P,$% @ S4MI4\LK\WTH!0 M 1< !@ !X;"]W;W)KY ME^2YTNJ55\]BSYA$7XN\%#>+O92']Y8EDCTKJ+CF!U;"+X^\*JB$V^K)$H>* MT;0V*G*+V+9O%30K%^M5_=U=M5[QH\RSDMU52!R+@E;?/K*["NZLUDN:%:P4&2]1Q1YO%A_P^YBXRJ!&_)VQ5W%V MC125!\Z?UK.P548L9XE4+BA\O+ -RW/E"?+XTCA=M#&5X?GU#^^_U^2! MS ,5;,/S?[)4[F\6X0*E[)$><_F9O_[!&D*>\I?P7-3_T>L)&]@+E!R%Y$5C M#!D467GZI%^;0IP9>-&( 6D,R,# \4<,G,; &1B08,3 ;0S<@0%V1@R\QJ"F M;IVXUX7;4DG7JXJ_HDJAP9NZJ*M?6T.]LE(ME)VLX-<,[.1ZPTO!\RREDJ5H M)^$#5H$4B#_"'4^>]SQ/625^1?&78R:_H7?W)3VF&:"OT!+=[[;HW2]7*TM" M*LJAE31A/Y["DM&P10'+I Z!;LLD!Y_E$_J0@FM8/S1'=S1+45:B#3UD$N[_ M_<2*!U;]9XBUF8^5244+28YNA3@RM-O3BHDII]MIIY^9A%T(-8MI54+JD[[B M:5]_<2#8-[.@C6TO2=M+4OMQ1_Q\I#DM$X;>0=E$3? *48FV++E&#OX-$1M' MIE:=O'JU5W6PO*S]P";$\\.5]6+(QVGS<2[*YY(<3I[\LQQ<[#MN%$5M#J=> MZT"[C]CJB*6+G=#W([^/C'4D<4/'=LRTW9:V.TE[1W.F]D]R6N.B7N-G/3'1 M=[46!+;ZP^94O#85[\VIF,)[6B&" .H0#FKO:5D.:S^+B'7$(%2/J-\2]:>) MGO9SIC9WBD _$14"9)8F<&R)^DR9:X&O)8:)5S?!G%K0IA;\W]1,Z01:2V - MVRX)!CT)9GLRBXAUQ#!6CWG8,@\GF8.V2#@:U<&;@,QD("1TC&XXE^1&1[C8 MQ62P1K>SCN)91SVR44LVFF_S4LTLJ=IN,,B)4;*18:G9=C3<;CILV-I91#P; MJD<6V]W88$_2_1-6<,Z%,$J_/7=&;QK(%#<#9.EZKD\&BA!? .R3/)N-\,\( MZHX=0,QL)6;$-A8 :QF%OJ<4=2RE3N+Q91I_41I$%U4GLD//)\-VZ". <7,9 M<*"M(<@K\89=T:$@KMCQO9$2=%,%OFRL>.N8T[B]?,[!G>+C:J0 MD-AC>[-3?#PM^3\S^V*#($<3@Q?N)!G/:/*%XV_CYKP7#FBDC_UA*^8E>1X2 M&R##DY0'UH]S@;DKP V:=Y]F@_K?MU9^N'B/J$2;B0 BU10L7>R%R7 M_J7C0\&']'65UNC/0F(#9!"MS[J3>O)34G\^^6 C?5WJ(^Q.G/&DDWIRL=3/ MIV&0^L /"*C-L ^FHL M%"AGCV!I7P=0QNKTOO5T(_FA?J'XP*7D17VY9Q2>[A0 ?G_D7/ZX4>\HV[?> MZ^]02P,$% @ S4MI4VC7&E #!@ ,A@ !@ !X;"]W;W)K48LDF1;LH]B66Y;FY8:Q!KU592VO)YNFV5Y. MIS+;L(K*3WS+:OAEQ45%&_@JUE.Y%8SF6JDJI\3SHFE%BWIRN.E?SU>H(G[R^^%>M-HUY,;ZZV=,V>6/-]^RC@VW1O)2\J M5LN"UTBPU?7D%E\^D$@I:(E_"_8J!\](A;+D_%E]^9Q?3SR%B)4L:Y0)"A\O M;,;*4ED"'#\[HY.]3Z4X?'ZWOM#!0S!+*MF,ES^*O-E<3Y()RMF*[LKF&W_] MAW4!AQDNI_Z+73M:;H&PG&UYURH"@*NKVD[YUB1@H@!V[ ND4R+%",*+@ M=PK^N1Z"3B$XUT/8*83'"M&(0M0I1.=ZB#N%6!>KS:XNS9PV].9*\%LLT8BOD(S*C=H 6M5 MH@_?:[K+"Y#YB"[0]ZG]!=N?4P5^XU>\M@D$81"0]E%O8',:CU_K(-M:+UF$A4U H(6 +)> M(RHE@RY&ZQR5!5T69=$43%XZEEFT=QUOKC MS88):-U"0"/M@-B2%AG9N/ #[VA%WENE!ID]B"'>QQ"?%\.'HFZ?/JIP:);Q MG6K^6_J++DNFPX&78L?Z&&VAQ ;(.(K#\"@44^J"!-@?;*Z#8))],,G_%@S* M=PPU'&:J4A/@E@JU3FPQ)@9ZZC2T]V-;T?=VHC'JYQ-<45 M8WA3,]M)$,9Q= 3:(A?&?D(".V[L]8.%Y]Z7"O5*CP\KP2LK<->&Q(,1!CMS MI#W1[.>N$) C-=^J3=>^D<58T^J,#B,_WGP6$8P#'(W4%),>,3FOJEO!7PH8 M1=#R%Q3WAX[%;I)]%#QC+.]**BGL*Y@4@1\J2#L,J]FS M%;%OP/&A[T?X>#%:!./8]_P1BL ]O6$WOSTI-D.%E#M:9PP 2WM3QB9'7?@1 MD-DQ4%/.&\'8\Q@.?W]1K(H:$)^Q*$)+BB-" B/%IJ SQ3TO8C_$%EDL]DG>3YPC!46 FWA3TL>\G(R2">TK$;DZ(?309S;"%7F\%[BZ#-X,+BV%:(!XN<,\$]:^/4 M27Y/N^VVU$=I6J*\D!F<3':"Z7-U]DZ,L$O:NR1@*!<3DIYSB7>ZKGHDS7=" M+5>81;M"(G %#AL&*!KK4=,[22M.D4/(/7F3,\C;"1G8!88T^F9O?.0TC3M% M#F'W#$Z(L\!?W\])@P9=YV=P^*&_GGB)FWAG XK5/-9-.NX9AYA\:B3'%,%^ MX@4D'DE1S[G$S;F?8?'7ZT+/WL/A[ 3DP-B2!F13! [!493Z(_,-Z3F8N#GX M!Q6"JCYH3;$Z8K0'8VF[_9H3DUL-[*9( ),9&:%?TM,O<=/O;7O>Z8\[OY'R MZ'3*31$<$S\Y/B5,!S>1%1-K?W1^SM\.<.6]W-\ M>6][O\"7#^WU=>^VO4W_0@60MT0E6P$$[U,,N1?M!77[I>%;?3^ZY$W#*_VX M831G0@G [RO.F_-TO>F0+3P4 II)D%A;?4^#$U68,G,0%4HZ62O=,DL;?4A-)5&EON@4H1) M%/T1EHS+8#KVMHV>CE5M!9>XT6#JLF3Z.$>AFDD0!X^&.WXHK#.$TW'%#IBB M_5AM-.W"'B7G)4K#E02-^TDPB]_/1\[?.WSBV)AG:W"5[)2Z=YME/@DB1P@% M9M8A,/K[#Q]4\Q=V]5PZO$P)XW^AZ7RC ++:6%5VP<2@Y++]9P^=#O\G(.D"$L^[3>19 M7C/+IF.M&M#.F]#?^3Q M1[_ 7^L#D_R;U_("%DH:)7C^).T/6I/VIVC -3>94*;6"/]L\<'"7*CL_M]3 MUW&>33R ^2Q=IK"^A>DL71UDW/>4S1-E4ZA:Y+!#<(." EW,EUJV+['AM@!;($D@ M:PH\"4'S!M99+6H#G[@; 5O,"EC*; "O7KYXER3157OL-_$5D+_#[,X6JJR8 M/':'KZ%4QA*9C+#%D=B4E<"6OLDH\1&9!G1="M?D5.Y0PS#V?18-0"K[L_G" M*453)6LS<7GX+:FXS$2=8ZL'@=7.2*W0U>ZZA).E*900QS>JD01DZIWA.6>: MHW%M1<42F]BHJ=KUXF]PZDDEU(%"*$)7@]?DH57I$SM^ M+BG+OM8D=MNN?C1<^N)+=H0X.B7-3U=TT65WL %TUP#T<&T7VKW>5L-3;RQ\ M-LVH@(.?V0:\-.U@ZZW]9V'63L,G]_:;\H'I Y<&!.XI-!J\O0Q MW.ZW5A5 M^=FX4Y8FK5\6U+&HG0.=[Q6)T&U<@OYC.?T.4$L#!!0 ( ,U+:5.]3)5" MGP( *D% 8 >&PO=V]R:W-H965T&UL?51-;]LP#/TK MA+%C%CM.TK5%$J!)/]9#TZ+IML.P@V(SL5!9\B2Z:?_]*-GU4B#-Q19IOD<^ MF>1D9^RS*Q )7DNEW30JB*KS.'99@:5P?5.AYB\;8TM!;-IM["J+(@^@4L5I MDIS$I9 ZFDV"[\'.)J8F)34^6'!U60K[-D=E=M-H$+T['N6V(.^(9Y-*;'&% M]*-ZL&S%'4LN2]1.&@T6-]/H8G ^'_GX$/!3XL[MG<$K61OS[(W;?!HEOB!4 MF)%G$/QZP04JY8FXC+\M9]2E],#]\SO[==#.6M;"X<*H7S*G8AJ=1I#C1M2* M'LWN.[9ZQIXO,\J%)^R:V#%GS&I'IFS!;)=2-V_QVM[#'N T^020MH TU-TD M"E5>"A*SB34[L#Z:V?PA2 UH+DYJ_U-69/FK9!S-EH804O@*-T;J+2R,SM#J M24S,[2/BK.69-SSI)SQG<&^%S=.CA"NL^C!,>I F MZ> (W[ 3.@Q\PR-"'9"!:ZF%SJ10L")!R U&[@C_J.,?!?[19_76:T="DR>^ M-/6:0*QY"#[>*_Q^PE>"N3+9\Y]#EWP\1]J'F_O;Y0TL[I>+J\?)#%^_=IB#U(16EM[CC)(Y2\UATVEWG78HQ O"&E$#CW4E+,<)QT/J M^8@3+!IZ;DRE/!U)77-:!P*VIDWJQ?7APH$KS$YS\H \E*[W@;-@&JFSVH:L MH(QS8#;P9= ;C4]Z@V\#X+T3$)KO K@IF&:-MNL,N,2L]0R")^''X*Q_(+0' MVM"A/QWOC4^)=AN6A&-9M:9FDCIOMX$^;0V?H-O.LW]02P,$% @ S4MI M4SK2SZ&O @ @ 4 !@ !X;"]W;W)KWR4,(@TG;F4X?A+U@363)E42@?U])-BYI$UZ\ MVM6>LS>OA@98$-46)7)SLQ6R(-JHK4B+) M'*A@?A@$5WY!*/?&0V=;RO%0[#6C')<2U+XHB/P]128.(Z_CG0PKNLNU-?CC M84EVF*!^+)?2:'[#DM$"N:*"@\3MR)MT!M.N]7<.7RD>U-D9;"4;(9ZL- MO, FA Q3;1F($<\X0\8LD4GC5\WI-2$M\/Q\8O_L:C>U;(C"F6#?:*;SD=?W M(,,MV3.]$H=;K.OI6;Y4,.6^<*A\>R9BNE=:%#78Z 7EE23'N@]G@'[P!B"L M :'+NPKDLIP33<9#*0X@K;=ALP=7JD.;Y"BW0TFT-+?4X/1X(31"!!]A*;$D M-(/X:.:M4 'A&3SH'"7,]E(BUS!1"K4:^MK$M6@_K6-,JQCA&S%NX%YPG2N( M>8;92[QO\FV2#D])3\.+A F6;8B"%H1!V+G %S5-B!Q?=*$)"K2 SY03GE+" M(-%$H_GY_JWW!7^WX>\Z_NX;_%4;J_;!G*J4";67"#_6>-0P92)]^OE:6R^R MVG4=J)*D./+,/BJ4S^B-HS8L5_%R'^/LR7B1Q I/%'![6M_$*9H^K5;Q8 MPR1)XG72S!S/9RY]>IONB=Q1KH#AUD"#]G7/ UGM>Z5H4;H=VPAM-M8=<_-$HK0.YGXKS"]6 M*S9 \^B._P!02P,$% @ S4MI4P&ULC55M;]HP$/XKIZS:)T9>H)1V@ 2%:I-:ADJ[ M%TW[8)*#6'7LS#:E_?<[.VE*MQ;M"['/]SSWW-EW#'9*WYDZ#GN ?O0&(*D!B===!?(JI\RRT4"K'6CG36QN MX5/U:!+'I;N4I=5TR@EG1W-E$;KP <9IJK;2&EBP1[82"$QFSJBWF,'L@1Z! M03,(+<5TR#"M^2<5?_(&_RE<*6ES S.98?82'Y+61G#R)'B2'"1<8MF&3M2" M)$KB WR=I@ =S]4, MQO.I,U[?SJ8P^[Z8S9>SY?.5EWO26"T-ZRN'5%$'&@MJ#39'6"M!CTOT;Y CZ$6M*(IH$?=:O9.HJ<8:*9S3T,3NGK:B?A?B MXU;O^-0!HLIP!)VDU4E._S.%]^_Z21Q_I"$BZ&8SJ1L"O;?NTQA7N=6Z#>^/GD MA)&6JHD;:S,"QU7G/[M7\_.*Z0V7!@2N"1JU3VCBZ&HF51NK2C\'5LK25/'+ MG,8X:N= YVM%K5!O7(#FCV'T!U!+ P04 " #-2VE3A?R8W+4# !_!P M&0 'AL+W=OK42%OV M!4@A!T@)25I.(5 @=ZI.]\'Q#JR577MK>TOX]S?V$DJKAMX7V+%GGGE_/-@J M_61R1 O/92'-,,BMK2ZBR/ <2V9:JD))-VNE2V9)U)O(5!I9YHW*(DKC^#PJ MF9#!:.#/YGHT4+4MA,2Y!E.7)=.[*RS4=A@DPQ@Q@M8(<^E*M1&H"%=7;7.!I&E>!QJQ/>^ MKQK?Z2N^^S!5TN8&;F2&V??V$>5Q2"9]2>8J/0FXQ*H%[3B$-$Z3$WCM0W': M'J]]HC@&K();(9GD@A6PM,PB#:4U)_ [!_R.Q^^\@C]%O4%MPN/B&V R@VMA M*O5R0 (OE*DU!?//"I\M7!6*/_W[LXJ?=.@V_,)4C.,PH!4VJ+]B,.JVX'+\ MZ6&RG*PFLWN8W<)X-IW??5XM'I8KF-R/7?-GB^G-XNXSS,9WL+H9?[R?W:UY M3BL%BFVPF[[116RE(_?PC!^>IU M^F'<.^'+2P[I^SBEDN^L\[8FQ<<"O\5B!:6-2">822>-J!R1]MO]7W?@ M?P_5SW8Q.B+%TBV:HWX#/HF&'P^GA]?ELB'5;^K-TS1E>B-H$0M&PO=V]R:W-H965T.3OGS&4OX[U4C[I"-/#"F="3J#*FODP2753(B8YEC<*N;*7BQ%A7[1)= M*R2E)W&69&EZEG!"130=>^Q.3<>R,8P*O%.@&\Z).LR0R?TD&D2OP#W=5<8! MR716LVH2^F(Q_:K^HWOW?:R(1KGDOVDI:DF MT7D$)6Y)P\R]W'_&MI_=V2FLCB\=Q8JRT"TB*5F869+)W9"Y@*86I-%R+$LM_^8DMJ:LK>ZUKEIT4 M7&,=PS#M0Y9F@Q-ZPZ[/H=<;GNA3@Y%P0P41!27,MDH,VO-E] G]4:<_\OJC M]^IU\,7 C-G0WV_-^'2*LQCFJ^5R M=0OKA]7\&SQ4Z':M)N( %=$@!8*0D*=I/PT_L%.T+6Y0=:.$!18M,O"(Q5<" MOC:6G/\7&(R"2A_FB]M>&I^GT!OV+S*?S4+0&\3!X.0 O2S. SK*^[G'WYIT M@>QRG?P!02P,$% @ S4MI4TC1 M(=V! P \0@ !D !X;"]W;W)K&ULK59M;]LV M$/XK!R'[,$#5NV(KM0W$SHJU0QVC3K[A/0^//$V.0CZJ/:*&IZJLU=39:]W<^+[*]U@QY8D&:UK9"EDQ34.Y M\U4CD176J2K]* BN_8KQVIE-[-Q*SB;BH$M>XTJ".E05D\]S+,5QZH3.R\0G MOMMK,^'/)@W;X1KUYV8E:>3W* 6OL%9B M_(T7>C]UQ@X4N&6'4G\2QY^QXY,:O%R4RG[AV-HFJ0/Y06E1=M-P?':',I:2UKEY*=G M2Z$11O &UEKDCW#?&*W4Q->$;2S\O,.9MSC1&9P,/HI:[Q7\5!=8_-W?IYCZ MP**7P.;11< U-A[$@0M1$(47\.*>:&SQX@M$%6@![WC-ZIRSDB@SC91@6EW M3WK\Q.(GY^+=,XEO3((4L&+/!A9NI63USFX!OS_@DX9Y22K_<4K>B^CF:MZH MAN4X=>CN*91?T)F-/%@_W"]^@?O5P_O[Y1KN#I+7.]![A 8E%P6@.0T@+8GH M!F4O*-QAWLV$=H;F*_;\+Q!8X@MG 5>E&PN%O"!U8?Z.6 *+,Q M)!Y<)5'BQH%9=2&,TA_>0N"%"35+7KZ%:_AP*'O[T#O)XRJB_G60+)9W0T[Q M*/TOG'JW5S@%WKCE=*@1PJ G%(6A.^H)&2O+R5*SG*RG-?"(7W^.'<0YCFGF M1LG8;#@XXF=DLCO@$_DPU(+T^2Y&^XKTJ4YRV M,IES;&.+2:8LR-SLFW./1@.-XM3(TV=,Q\H[1?0JOL[<-!N9?4Z*%\>49&,; M!Q^H$J7_IR8]VJN*)#:2GLA %B!-'P,E"N=>;A:2E"=YQE9X5(8C>) M[?*I%],?E*$*Y_@Q\9'+'2",J MG[(ML.U B\86M8W05")M=T__)"B- :UO!;WWW&PO=V]R:W-H965T]?>R7CPAD-ZKVE&@WDWA1-!GZW!9K*5 M->3)T?"L("XR-96#T>\8[+ I+1#)^'SF=-J0%GJ]/[/=U[I3+EFF\D\4/ MGIA\Z/0=2#!E^\*LY.$K'O.YLGRQ+'3]A4/C>^T[$.^UD>413 I*+IH_>SG6 MX0S0_P@0'@%AK;L)5*N<,L-& R4/H*PWL=E%G6J-)G%(^4MG+#D]Q)>)%PC54'(M^%T ^#"WQ1FWY4\T47TM=@)-QSP43, M*>^U80;IV1E]@;_;\G=K_NZ'>O];59AR'1=2[Q7"SPV^&)@4,M[]>J_:%X/9 M_KW5%8MQZ%"#:E3/Z(SZ'5C/'A[FBR\D8K:8K<8/,%Y,83Q]G"_FZ\UJO)D_ MS6"3(VRIJW>)/ B0*>B3\NQ,.7NKG&8"& )6J+A, .TETT.JJ'Y;5.T]47$M M5.WVH@ >F=JAL6Y1X$:]+BR53%';YJ?@M6_@AVZ_ MY\.*+@?"&[=_U8-O:_?IG;5.B2JK!X2& M6.Z%:;JHW6UGT+AIO;_NS0"C##(N-!28$M3O]*X<4,U0: PCJ[H1M])06]?+ MG.8H*NM YZFDUW@T;(!V,H_^ %!+ P04 " #-2VE3ZF/'IS " #>! M&0 'AL+W=OT>>GTPB2 ^'#NUE=%^^\E.R-ANS4MBR])/?]FRIT=C#RY' M)'@KE':S*"SZ&9XO1A[_^#P)/'HSL;@*]D:<_"393:+!EX0*DS)$P3_?N$M M*N5!+..U849M2A]X/C[1[T/M7,M6.+PUZJ?,*)]%GR/(<"H+ MU"@7OG"L?:^2"-+*D2F:8%902%W_Q5NS#V!= M?L [E0;/*RRV:%\ZF)]\]]QS3WP>;95^,"6BA5TEI!D'I;7U9129 MO,2*F1-5HZ23M=(5LV3J361JC:SP296(TC@^C2K&93 9>=]"3T:JL8)+7&@P M354Q_6N*0FW'01+L'7=\4UKGB":CFFUPB?9+O=!D13U*P2N4ABL)&M?CX"JY MG Y",C\4XB!TA%)A;A\!H><09"N& B,;/#C/H2[K$ MP_T>_<;W3KVLF,&9$M]X8G7Q2%B&#M[#06#->P/6._K=! TP6\-F6J&'6:(W2PI4Q: V\OF;-*+)$P,%$>5=LVA9+GREV ;=*VM+ M2RP^#<_(N(]^W3/?IH>!5QB?0)9 M'$(:I\D1O*Q7(_-XV1$U#+3]'8$;]' ##S=X!FZ.:R3I"I@I8TT(,U9SRP3_ MC46X%SP\$+H3>,Y-+I1I-,)WSP7N<6=A*E3^\.,IU8^R<&-]:6J6XSB@N36H M'S%PREFL5E1T+Q_,,>\\B??$_9W _9UX"6DXB#-:DS#.8E)J!W>4QA\]S54=]2E9P)N']\A[.POCL H9A/$PI[R(&UL?51-;]LP#/TKA-##!F2Q MXCA?11*@:3MLP#H$;;<=AAT4FXZ%RI(GR77Z[R?)CIL!;2ZQ2/$]/C*DEHW2 M3Z9 M' HA30K4EA;74:120LLF1FJ"J6[R94NF76FWD>FTLBR "I%%%,ZC4K& M)5DO@V^KUTM56\$E;C68NBR9?MF@4,V*C,C1<<_WA?6.:+VLV!X?T/ZHMMI9 M4<^2\1*EX4J"QGQ%KD:7F\3'AX"?'!MS<@9?R4ZI)V]\S5:$>D$H,+6>@;G/ M,UZC$)[(R?C;<9(^I0>>GH_LGT/MKI8=,WBMQ"^>V6)%Y@0RS%DM[+UJOF!7 MS\3SI4J8\ M-&SN+":2UL:KLP$Y!R67[98>N#R> .7T'$'> ..AN$P65-\RR M]5*K!K2/=FS^$$H-:">.2_^G/%CM;KG#V?5W91$2^ 17::IJ:0ULV0O;"00F M,^_4-69P>W!#8-# AT=_9SXN(^N2>XHH[1)MVD3Q.XD6<*>D+0SLAC"F XAI/#K#-^X[,0Y\XS.=,-#6=X8NZ>F20)>\)\^M M3U:[/JK\?&^_<;;C@EONLO\.Z>$1#Q8V0J5/?]YJ]-G$?HLO3<527!&WI@;U M,Q+?+(OE#G7?,;C!M/.,@H>^RJPZF1ZFET,K@EZGU83P-!1CO#O;=_ :[:P7\- M;Y^/.Z;W7!H0F#LH'L6ZIP+-PKAMH'N/M&ULG55M;]LV$/XK!W4H$D"S7FPG=FH;L-,6#= 7(\FV M#\,^T-19(D*1*DG5\7[]CI2BI<-J!/TB\"-FV(9I9X02N3.(S!Z?<-KE-(#$8VO M/68T7.D#GZ^?T-^'W"F7';-XK>4?HG#5,II%4.">M=+=ZL,'[/,)!+F6-CSA MT/NF$?#6.EWWP<2@%JI[L\=>AY<$Y'U 'GAW%P66;YECJX71!S#>F]#\(J0: MHHF<4+XH=\[0J: XM_JL'<(4?H4U_]H**X)4>@_7NF[DT1EB #>*C^#,BX!& M'N$+EW"/O%):ZE*@)5_3C,[A[)[M)-KS1>*(F(=/>$]BTY'(?T!B#I^TM-:.K7V>0%L#+OC=Q7Y,]Q-LC\ZV$C-'_[Z/Y5/WNK; M^\HVC.,RHOZU:+YAM-JVAE?T5IFFJHD## L?7KV9YEKV! S.&*6=ADDWB+)_!/9F6=5W(M:63 MZ22>CG.XUXY)^ \%?]=L,H_3V26RD[G;4W[+ZO!238OJL%:$G@GZ36SE1?$"WDQ)XI< MMU[9AAT#%T^U:!'V1M#Z>_UP%DF?CAD9"&8:JA<"MFSS#[C"WU]VX^M>]&_J?F"F%LB!Q3Z'IZ)+D M,]T@[0RGFS"\=MK1* S+BOX]:+P#G>\UM69O^ N&O]GJ'U!+ P04 " #- M2VE3A$WC>F\" I!0 &0 'AL+W=O/57FJ1%8J#IVFV';D'3;8=A!\6F'2&RY$E*D_[[4;+K M94 ;[!*+$OG>(Z.GV5[IK=D@6C@T0IIYL+&VO8PB4VRP8>9,M2CII%*Z899" M74>FU6.I^IG15>.> MUQOK-J)\UK(:5VB_M4M-432@E+Q!:;B2H+&:!U?)Y6+D\GW"=XY[<[0&U\E: MJ:T+/I?S(':"4&!A'0*CSR->HQ .B&3\[C&#@=(5'J^?T6]][]3+FAF\5N(' M+^UF'DP#*+%B.V'OU?X3]OV<.[Q"">-_8=_E3L8!%#MC5=,7DX*&R^[+#OT< MC@JF\2L%:5^0>MT=D5?Y@5F6S[3:@W;9A.86OE5?3>*X='_*RFHZY51G\R_* M(DSA/:QH,%S6(7Q$B9H)8+*$JY(HN;&:N=G!VP>V%FC>S2)+U X@*GJ:14>3 MOD)S 7=*VHV!&UEB^6]]1)('W>FS[D5Z$G"%[1ED<0AIG"8G\+)A#IG'RT[, MP4#7WPFXT0 W\G"CU^21>#&MER5I^N:&W#+5+H/-*T47H T'+.G+F8L7L;(5_5"D"C]YQQU?=66J^O?5]E*\B)NA)KX.;+0LB< M:+.42U^M)9"Y(^7,#UJMV,\)Y=Z@YVQ3.>B)0C/*82J1*O* MD,"S 13[A=M2FP4>R@KE!9Y1381Y)27 M3_)>U6&+8/PT$X**$.P3P@.$=D5HGZH05H3P5(6H(D3[A$-)QQ4A/E4AJ0B) M:U997=>:E&@RZ$FQ0=*BC3?[XOKKV*8CE-N=^*BE^4H-3P]^"@TH0)?H5E"^ M1"/!,Y 5N1Z!M #S?2',<5,MK$!]X1K\!5!+ P04 " #-2VE3669, MXE(" "M!0 &0 'AL+W=O5>FKB]J4P3L=:,3?>V!B._(";[\QHZM"VPT_32JR M@CGHIVHJ3>2W+#DM@2LJ.)*P''EWP>TXMODNX1>%K>JLD76R$.+9!M_RD8>M M(&"0:_8'Y]UX61 %8\%^TUP7(V_HH1R6 M9,WT3&R_0N.G9_DRP91[HFV3BSV4K94690,V"DK*ZS?9-77H (+X#"!L .%; M 5$#B)S16IFS-2&:I(D46R1MMF&S"U<;AS9N*+=_<:ZE.:4&I],?0@.*T$.#@^"7< M-X5KJQ>VU0L=7WR&;^\>&O>G#-4,?<=@9VJ3AC&.$G_3E7V<%. (MTDOQ$6M MN.A5<8]DAV:0 =V0!0/TX=TP#()/:$PXR2GAZ,O\\93>FK37D3+ @YL#O<=) M/=P+3^N-6[WQFXK9M%*GD^H.NMIWU"G5\5$!;^)A>*#Z.*F/AX>J_&ULC51=;]HP%/TK5K2'5F+DD_1#(5(+FS:IFU!9MV>3W(!5 M)\YL!^B_W[639K2$#1Z(KWW/R3GWYCK9"?FL-@":[$M>J:FST;J^=5V5;:"D M:BQJJ/"D$+*D&D.Y=E4M@>865'(W\+S8+2FKG#2Q>PN9)J+1G%6PD$0U94GE MRSUPL9LZOO.Z\_QJ%"C, M6[;M)J(X$W(Q!TT95Y<(?EK.R<6'R\35*-T(<+-.YGTK,S@AB 1> MX _ 9_^&SR%#N&_AWENXBP7KJQ;T50LL7W2"KW=>M\Z'#+4,L64PL[1-8P]_ MB;L]U'V@,^CM/" M( S>^W /!LI<9M^H7+-*$0X%XKSQ%19"MA=$&VA1VQE;"8T3:Y<;O%-!F@0\ M+P3.61>8L>UOZ?0/4$L#!!0 ( ,U+:5-*AD1W000 !(/ 9 >&PO M=V]R:W-H965TPGC:6<^ X1N 00D8O 2,WP ,2\#0*5.XXG0(F6'SF9);HNQNM&8'3DR'1O=Y:N-^ M:Q0^Y8@S\P_2 !F17\A9]#7GFKM@R!59R"03.Z.0 ;E,HS[I6IE!B1VYC@2Y M@VB32B'7'#3N55G_B'1#,(P+C0\?3<[$$5K]=!N2[D]',\\@5_M&+RIYG1>\ M@C=X3%PO\F?=G@(&(,!;8(_\V90Q7W@[ W?L'>>:US1-GC)DJ?,QKV'$TSH&)2; MDCO%4KT"I2#ND0L\'F:'9\& FTTN=0ZAYBP-'9#MA30%.:"QMC1L)?0PQSI M/]1U>[V##B;^,#BN]CWS<%AY.&SU\)XIY(]$+4-WGVERG1MM<,[3=1/7X2LF M0SJDP>0YX?#=;<_XCBJ^HU:^ETG&.*98:FS^H_$8B=Q2 M)[])&6^Y$$<]EX/!U,FUF.*Y;C5I;7BS]>)S_YZPJ2):B_ M6P[FY>KD'Y;(:+[2D3;2U&+I#5* M[XHU^E:Q]D6(ME>A%H(7CU@JN 9RHW@$M3TOPQQ+(9C2),,3XKQH=J(@,JE_ MOV#!H&]XL*]RM+WNO!-N+.R@$M+]$YAJYM5N?D1VB-1-5X17:Q;P@W[MFBY- M(IFGIO@:KE:KQN[,M3,OUL_IR:)HS_9FBF[QBJDU3S41L$*3?O\8SX J&K!B M8F3F6I*E--C@N.$&FU90=@,^7TEL2\J)?4'5!L__!5!+ P04 " #-2VE3 MQOT&H/L" "W" &0 'AL+W=OWR-+6-&"FTNY^0Q5/!W+ETBNW2_95+:!1Y)"&YE58%20,5'^T\P#M"M#>!73W .(*$+O,E*&X/,RHH>.ADANBK#6RV0>7 M3(?&\)FP95\8A:<,<6;\51H@'?*!G";W!=/,%4.NR%1F.7\R"A60,Y&TR)%- M,RC^1"X23JX@287DD[9)#K( MN("\1=K!>Q(%4=@@:/IV>- 4SV'X#+ 8[; )_B*:=MT ;<<7[^'#0F=8&T1MOM!'/5JNQ=RXUIN?%#N MQ?3+Z^8CW\\ANP7UXT ^.K6#SK_/QZSS9]%V:S'=@V*N%!6:EC=D(K713;Y+ MBLZ6[T[<:4?-GGNUY]YAS])0OO-"-SGOO7(>]N-!T-\3>+]VW_^+,I.?Y(8J MS(W1Y*PL$1-H(D0U36Z82=4HU<(ZJ+]5QK\ 4$L#!!0 M ( ,U+:5/F=Q,@/ ( *P$ 9 >&PO=V]R:W-H965T6*DE(4!;K0(2EU9=J;N+EEX>JCX89R#6.G;6=F#Y M^XZ=D%*UP /QC&?.G#.927;0YMD6B Y>2ZGL)"J"4;K9^]<9=/HL030HG<>01&CSTN4$H/1#1>6LRH*^D3S\\G]$]!.VG9,(L+ M+7^(W!63Z$,$.6Y9+=V3/GS&5L_8XW$M;?B'0QN;1,!KZW39)A.#4JCFR5[; M/IPEI)<2TC8A#;R;0H'EDCDVS8P^@/'1A.8/06K()G)"^9>R=H9N!>6YZ8-V M"&-X"S/^4@LK0JOT%A:ZK.31&6( =XKWH>>;@$8>X9%+^(J\4%KJG4!+L:;J MWQ#&JC:\H!;!R@B.T%NB8T+:&^BMF$'E"G2",W)DL2/NGD',6Y[SAF=Z@><@ MA7M-"!8^JASSOP%B$MTI3T_*Y^E5Q"62JN'@#:1)FMB""-HKJ,.NG\. .KJ M^KCX\F]SX.<]EALTOZX4&'4%1E<+K -3$-;6F$-/*&BX_[>G#=0X0/GUW%,? MQXG_9?'^G$1\-D'TEG=A3RQP72O7#%/G[59QUDS@G_!FC^^9V0EE0>*64I/^ M>RIOFMUH#*>K,(\;[6BZP[&@SPD:'T#W6TTSV1J^0/>!FOX&4$L#!!0 ( M ,U+:5.2[-T&: ( %,% 9 >&PO=V]R:W-H965T8EOY[N<$Q^G6Z6?3 E@R6LEI)D%I;7U91@:5D)%S4#5(/&D4+JB%I=Z M$YI: \T]J!)A$D63L*)PTL0T547U[@J$VLZ".'C;N..; MTKJ-,$MKNH%[L(_U2N,J[%ER7H$T7$FBH9@%\_CR:NSB?< O#ENS-R$-IX[SJ"7=,#]^1O[-Y\[YK*F!A9*_.:Y M+6?!14!R*&@C[)W:?HJP!TCB M(X"D R3>=ROD72ZII5FJU99H%XUL;N)3]6@TQZ7[*?=6XRE'G,U^*@MD3,[( MG#TWW'!?*E60A:IJL;,:'9!KR0;DQ!4!M-B16R;( [!2*J$V' S&ZGIPBARK M1K,22T16FC,@1("DM >\/X*TFB)'J\7Y*3+Z?_LX18E+XR25^9Q-..CM NJ"D/F6E1$X]R M5_XEB^-1/)FFX'3+7DXSU39\D0ZQ$?=C7J78T^=74M+94;[OT8 _:0].B#=#R=3*;#(P49 M]]+C3Z4?E*7BW8TZ)#_^^#LN1M/HXOR=?+C7(^ZYN:%ZPZ4A @I$1H-S)-)M M"[<+JVK?-FMEL0G]M,17#[0+P/-"8>MT"]>)_3N:_0-02P,$% @ S4MI M4S6 &C19!0 318 !D !X;"]W;W)K&ULM5AO M;YLX'/XJ5K07G=0+X 223&FDE72[3K_S\_CX.TQUE/WB(L0#/,4GX52\48OO.LG@0XACQ/MWB1'ZS MIBQ&0MZRC<6W#*.5-HJ)!6W;LV(4);W95#];L-F4IH)$"5XPP-,X1NSE&A.Z MN^HYO?V#+]$F%.J!-9MNT08OL?BZ73!Y9Q4HJRC&"8]H AA>7_7>.^\^PI$R MT"N^17C'*]= N?)(Z0]U<[NZZMF*$28X$ H"R8\G[&-"%)+D\3,'[15[*L/J M]1[]@W9>.O.(./8I^1ZM1'C5&_? "J]12L07NOL=YPZY"B^@A.O_8)>OM7L@ M2+F@<6XL&<11DGVBYSP0%0/I:+,!S W@D<&@S6"0&PR.#=HH#7.#8=<=W-S M/?;!:3'P<@.O*Z51;J"S;V71U:F9(X%F4T9W@*G5$DU=Z/QJ:YF1*%&EN!1, M?AM).S&[HP(##_P&?!K'LC26@@8_P,4<"Q01#A[PLT@1>0O> OP$#',092 MKTDD^.71PX>0IAPE*SZUA&2F\*T@9W&=L8 M+#ZE21\XPTL ;>A\7<[!Q9NW M&7 #EG\&EO]>8Y5$6U'G'5!M5Z/:'>!NS'!+O.V#@7W@< ?4#]U1[1RU >6C M&66. XGB=''5DM56E!PL2@YJ_&$+?K72+L$=!0O$P#=$4@PN9!FM*"&(<;#% M+-OY+?BW4FE-L<[V\_1^:O8^S>RI]53UV+3BP(E!X<3@#">661.\3T5(6?0/ M7FE/,L)-&;C)P-T*']?._XZ8=UEYX,&P\&!XM@>7X#X57,@FCI+-);C1G^ : M$90$^)1/PQK3B3.$T/4F1R[5%XX]]W#A@4=NX9%K]&B!7J1("@[H.I]CMYRG MFKI/N7PNZZB)N%LKCH$W&!TEXD-]54L"O(*N9Z3['3&&%%W%4I:,C*Y/DR37 MZ%TD0K!@T1.2 WI!4("5;^"OSSA^Q.QO0Q^.BOU'QOUO?J:1> 'WZS5F.MUW MJ8)6T2NH+>2]&O8G>E&KDF.6H MYDG6*H4"5!PYMV6\6LO8_7$+WU*]'+-\+1@-,%YQL&8T+HM,-LX2$3U6,X]D M!U&!2&/41_6:LR=CS_&.H]ZP< (-42]ESC'KG*%^]@>T[&S958F=SE+FE%KF MF,7LE3WM.W4Y&KIN6]!@*4G0K!GW_A]2=8(PH81NM/I3MNW2U[ 4$F@6DM)- M6?/S5.5&I2"BJ_*L?(=WV0I^(BGS?+.#I$#7T+:P\F/*K!QY>61,JTVKOWA% MN\[S#0_;U6F1.%@* S0+PVWRA+F@\CS3)5'E?(?F^?Z+$U7_;3+2:6KI(5@* M!30+Q?^0)_>\09[]!U!+ P04 " #-2VE3L0020<$' ^.@ &0 M 'AL+W=OI*K92"YS#& M51(IC6D#;5J4M*E6J_W@P"18]<':)H>T?_R.C?'8X/$,AV'[H3'PWO,[YOC- M>'SZ'(2_HRFE,7CQ7#\Z:TWC>/:ATXG&4^K943N849_]\A"$GAVSC^%C)YJ% MU)ZD2I[;09K6[7BVX[?.3]/O1N'Y:3"/7<>GHQ!$<\^SP]>/U V>SUJPM?SB MQGF-2/G, '(7TX:UW #]=Z-U%()>X< M^AP5KD$2RGT0_$X^#"9G+2WQB+IT'"!^\N9Q-.S5J\%)O3!GKOQ3?!\1;. ],3>.'"C]'_PG,EJ M+3">1W'@9[7:8I5E MN>%JO<4JRX+#M.*=15M,&[)EQ_;Y:1@\@S"19_:2B[0WI/JL_3I^TG%OXY#] MZC"]^/Q;$%-@@/?@-@[&O\'W6=*=(O#6HK'MN!'X05_BN>V^.^W$[&Z)3F>< M6?ZXL(P$EH=SMPT0/ %(0_#RP@)OW[Q[ SH@FMHAC2KL74KLV3ZS9PKL":U: M]58M.LZ]U-2M]M5CUQ3,?:HW=TMG;8"U1>@_;U,G*ZQ\5K>BB:UC>UGC#!TSGLFMC MIYVG8D.L$&,D8?;*8H-U,1T;&C3+8E^DUDJIP'DJ<&TJ;@*7??58&OC R+5] M\-YI^'=-ODE^$Z*<[\O 2W)KIS !#*)HSF1M?P*^S^,H M9A>)DTS78UJIN0C)U+?L5JL MR?:]F1N\4EJ22MNT$R[2SN9(FJ29329SQJG+^82HU+R;N]K=N>;@_A54]L5G M.YR<+*?A$_"9:<015($Y>B,C:+KY='UCA/=KW05P:0OGFC(5D7+ M7RD8A[<]&$ MT$$2PJ(=0XUFI-1U%P_H*-RAZOZ8RM.IG\7> RFZX3OX(;-JY4(FV] MEQ#IDO$1%D >'CWB'S3TP-L_J1U6('7NZRU(:DM-2<76(\NARBUY3PY$\HP M1-BTZWV43?R0(Q36(\\^Z[8W*=04R=KR-D$'@Y.=F3K MJ\S5(GYB0Q?B)^+L@AIGEWW@]57FIG* '%50XZAR*,(>9J$4!WBM+1C?46$; MIG%\48?L(5K?04$0&L)"T\XI@ M(/%1M(4XW%ROG"7.<:AQCFML)3',?#>5)AI.=DA],VO3A41FNK0YT]--M+*. MJ!!C0D3D.F<]5,]Z2E JC2_3V].: 7.(PXU#W!9KAH'$JZHUPZ**6RB6,\/I M#]?3W]X7&^[K\EDK5JHAIS1\.$K;<;71SUPMP7BW9K<;%YZ#-0YQ^UAN]#,W MU2/DZ(4;1Z]#K3<^XO4-):V-=4$*.%7AQJE*?<'Q$:]O+9F::0HKR3D''Y]S MY N.OL1+^;8^YLR"C\@L2LN&OL1#.?QCCBNX\6=O^X;_OL1E!O%&;:DY\.#& M-[=VAOB^Q$<9!A .2.2(3^AV'(7[F>]JHS#AZ$/4-[XVI?',=&D3IVL@!%=P MO$(.8X)[>EGN:Y6]'L;:RF."ZRI[75,W#4$R.%V1>KHZ" ?NR/N$4Q1IG**V MX/V^Q"LIMI/"2:9ZB-ISN2PZ3K4V0G?">8<1I.!ND?6]'$/O M"0O)T88<'VWDW&Y)O)1SN\[Q1C_^ :1Z;K=@HQ_M\-&VW&Y)7&8S M(ZHM-0<9_6AGD92YW9+X*#V'RT%'/^(SOUT'X/@$L?F"6M;; "AHN7%1?DA>*,M?&3W_#U!+ P04 " #-2VE3 MB:.+Q>," #H" &0 'AL+W=ONJQ8K**DZ%VO@^"87LJ0:AW+IJK4$ MFEE06;B!Y_7,PDT1MRI+*EQ$48CMP?.=UXHXM5]I, MN,/^FBYA#OI^/9,X1!B$: *QJ+XQ3*] M&CBI0S+(Z:;0=V+[%>I\8L.W$(6ROV1;QWH.66R4%F4-1@&Q"E$-B(Y5B&N 3=VM%FU!-AWTIMD2::&0S#[;Z M%HWU8MSLD[F6^)8A3@^_"0TD)9_)'->*\>49^0(<)"T(Y1FYRE"2*2VI6#^?D)-/IWU7HVDC[2YJ@Z/*8'# 8$AN!=0+R0%46VH55\]RF0OL:1CTDA#3>&JQ M$#46HDX+MU0^@D87;8H5--Y1#/TPB=H5XT8Q[E2<29&#,C7[AQQP=L<)/OY M!FGH'<@W;2RDG1;^XKXY(S^$ID7;#9/N[3O?#WO>6WFJ@[L?EF)4_#YJLA\5 M^A=^&+P/F^Z'!5X411^7Q-VYNDN02]LS%5F(#=?5,6QFF[9\9;O1A_F1?SGV M6^8GV,:KKOM&7WT#X,%9,JY( 3E*>><)+IZL^FHUT&)M&\>#T-B&[.,*/T5 MF@!\GPML'O7 "#0?-\,_4$L#!!0 ( ,U+:5.@'8O4%P, ) 1 - M>&POBA++ MCD"6/%GIDO[ZZ2S'25-=R/JPM7-(+=VG^^[3W;DR&==F+=CM@C$3K$HAZY0L MC*D^AF$]7["2UN>J8M(BN=(E-7:JB["N-*-9#4ZE" >]7AR6E$LR&5V: M.IBKI30IN>A,@;M]R5+2CR](X.BF*F,IN3]]_W.IS-6[P-U//IR<].[/KO;M MIPUP1D(OZ? (TO,>SFLQC#H^COH@-TI^>23Y879''[;YGXQS);=EB(@SV/BT M9,$#%2F94L%GFH-73DLNULX\ ,-<":4#8^MO!?7!4C\ZN.]FT!HM3\FETDUL M%\']G;7+]X#-# 1R(3J! ^(,DW%%C6%:7MM)L[@Q/H."=GRWKJS"0M-U?S D M6X?F9H/,E,Z8[L+TR<8T&0N6@QS-BP7]2]M[$6]0\0=E/B_M=F0S MAW9A-YKE?-7,5WDG &/OX^RTJL3ZD^"%+)G;_-$!)V.Z\0L62O-'&PU:96X- M3)/@@6G#Y[N67YI6=VQE-NVTRG'-@S>H^>_FN6"2:2IV1=O>?\U9?K'BZ/)? M26[^J^P+]FIL#\/7+G+X%D3&;T'DZ^S)L#UV=LZV)R=;9PW@#2(EW^&-16R# M!K,E%X;+=K;@6<;DLP/.TALZLZ^;3_CM^HSE="G,70>F9#O^QC*^+)-NU0TD MHEVU'7^%[?7C[O7%QN(R8RN63=NI+F;-,+ #&[6]P&$?N6XN/X+Y.,R/ (;% MP11@/LX+B_,_[6>$[L=AF+:1%QFA/B/4QWGYD&GSP>+X?1)[^7>:)%$4QUA& MIU.O@BF6MSB&KY\-TP8>6!R(]&>YQJN-=\CA/L!J>JA#L)WBG8CM%,\U(/Z\ M@4>2^*N-Q0$/K I8[T!\?QSH*;]/%$%5,6W8$XPC28(AT(O^'HUC)#LQ?/SU MP9Z2*$H2/P*87T$480@\C3B"*0 -&!)%S3FX=QZ%FW,JW/X&,_D-4$L#!!0 M ( ,U+:5.7BKL

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end XML 43 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 66 211 1 false 18 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation and Business Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business Note 1 - Basis of Presentation and Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Going Concern Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern Note 2 - Going Concern Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets Note 3 - Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses Note 4 - Accounts Payable and Accrued Expenses Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Common Stock Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock Note 6 - Common Stock Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Stock Options Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options Note 7 - Stock Options Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Selling, General and Administrative Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative Note 8 - Selling, General and Administrative Notes 14 false false R15.htm 014 - Disclosure - Note 9 - COVID-19 Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19 Note 9 - COVID-19 Notes 15 false false R16.htm 015 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables Note 3 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets 16 false false R17.htm 016 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables Note 4 - Accounts Payable and Accrued Expenses (Tables) Tables http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses 17 false false R18.htm 017 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables) Tables http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp 18 false false R19.htm 018 - Disclosure - Note 8 - Selling, General and Administrative (Tables) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables Note 8 - Selling, General and Administrative (Tables) Tables http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative 19 false false R20.htm 019 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern 20 false false R21.htm 020 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 21 false false R22.htm 021 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 22 false false R23.htm 022 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual) Details http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables 23 false false R24.htm 023 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) Details http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables 24 false false R25.htm 024 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals) Details http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables 25 false false R26.htm 025 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details) Details http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables 26 false false R27.htm 026 - Disclosure - Note 6 - Common Stock (Details Textual) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual Note 6 - Common Stock (Details Textual) Details http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock 27 false false R28.htm 027 - Disclosure - Note 7 - Stock Options (Details Textual) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual Note 7 - Stock Options (Details Textual) Details http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options 28 false false R29.htm 028 - Disclosure - Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Sheet http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Details 29 false false All Reports Book All Reports ovtz20210930_10q.htm ex_303261.htm ex_303262.htm ex_303263.htm ex_303264.htm ovtz-20210930.xsd ovtz-20210930_cal.xml ovtz-20210930_def.xml ovtz-20210930_lab.xml ovtz-20210930_pre.xml oculusvision.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 true true JSON 48 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ovtz20210930_10q.htm": { "axisCustom": 0, "axisStandard": 9, "contextCount": 66, "dts": { "calculationLink": { "local": [ "ovtz-20210930_cal.xml" ] }, "definitionLink": { "local": [ "ovtz-20210930_def.xml" ] }, "inline": { "local": [ "ovtz20210930_10q.htm" ] }, "labelLink": { "local": [ "ovtz-20210930_lab.xml" ] }, "presentationLink": { "local": [ "ovtz-20210930_pre.xml" ] }, "schema": { "local": [ "ovtz-20210930.xsd" ], "remote": [ "https://xbrl.sec.gov/country/2021/country-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 211, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 48, "http://www.oculusvisiontech.com/20210930": 8, "http://xbrl.sec.gov/dei/2021": 6, "total": 62 }, "keyCustom": 14, "keyStandard": 197, "memberCustom": 13, "memberStandard": 4, "nsprefix": "ovtz", "nsuri": "http://www.oculusvisiontech.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "shortName": "Note 4 - Accounts Payable and Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Note 6 - Common Stock", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "shortName": "Note 6 - Common Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Note 7 - Stock Options", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "shortName": "Note 7 - Stock Options", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Note 8 - Selling, General and Administrative", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "shortName": "Note 8 - Selling, General and Administrative", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30_UnusualOrInfrequentItemAxis-Covid19Member", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Note 9 - COVID-19", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19", "shortName": "Note 9 - COVID-19", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30_UnusualOrInfrequentItemAxis-Covid19Member", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets (Tables)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "shortName": "Note 3 - Prepaid Expenses and Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses (Tables)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "shortName": "Note 4 - Accounts Payable and Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Note 8 - Selling, General and Administrative (Tables)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables", "shortName": "Note 8 - Selling, General and Administrative (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "shortName": "Condensed Interim Consolidated Balance Sheets (Current Period Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Note 2 - Going Concern (Details Textual)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual", "shortName": "Note 2 - Going Concern (Details Textual)", "subGroupType": "details", "uniqueAnchor": null }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "shortName": "Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "shortName": "Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2020-12-31_BusinessAcquisitionAxis-OCLTechnologiesCorpMember", "decimals": "INF", "lang": null, "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2020-12-31_BusinessAcquisitionAxis-OCLTechnologiesCorpMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "shortName": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2020-12-31_BusinessAcquisitionAxis-OCLTechnologiesCorpMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PaymentsOfStockIssuanceCosts", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Note 6 - Common Stock (Details Textual)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual", "shortName": "Note 6 - Common Stock (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2021-06-14_ClassOfWarrantOrRightAxis-WarrantsIssuedInConnectionWithPrivatePlacementMember", "decimals": "INF", "lang": null, "name": "ovtz:EquityOfferingNumberOfWarrantsPerUnit", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Note 7 - Stock Options (Details Textual)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual", "shortName": "Note 7 - Stock Options (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-29_2021-01-29_AwardTypeAxis-EmployeeStockOptionExpirationDateOfJanuary292024Member_PlanNameAxis-RollingStockOptionPlanMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:FilingAndRegulatoryFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "shortName": "Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:FilingAndRegulatoryFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "shortName": "Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Operations (Unaudited)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "i_2019-12-31_StatementEquityComponentsAxis-CommonStockIncludingAdditionalPaidInCapitalMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "shortName": "Consolidated Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2020-01-01_2020-09-30_StatementEquityComponentsAxis-CommonStockIncludingAdditionalPaidInCapitalMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-07-01_2021-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Note 1 - Basis of Presentation and Business", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "shortName": "Note 1 - Basis of Presentation and Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Note 2 - Going Concern", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "shortName": "Note 2 - Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets", "role": "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "shortName": "Note 3 - Prepaid Expenses and Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20210930_10q.htm", "contextRef": "d_2021-01-01_2021-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 18, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "ovtz_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer in shares, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Shares issued (in shares)" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableShares", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals" ], "xbrltype": "sharesItemType" }, "ovtz_ClassOfWarrantOfRightStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for the conversion of warrant or right to be accelerated", "label": "ovtz_ClassOfWarrantOfRightStockPriceTrigger", "terseLabel": "Class of Warrant of Right, Stock Price Trigger (in CAD per share)" } } }, "localname": "ClassOfWarrantOfRightStockPriceTrigger", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of warrant or right must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays", "terseLabel": "Class of Warrant or Right, Threshold Consecutive Trading Days" } } }, "localname": "ClassOfWarrantOrRightThresholdConsecutiveTradingDays", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "integerItemType" }, "ovtz_CommitmentToIssueSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents commitment to issue shares.", "label": "Commitment to Issue Shares [Member]" } } }, "localname": "CommitmentToIssueSharesMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "ovtz_ConsultingExpense": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred for consultation.", "label": "Consulting" } } }, "localname": "ConsultingExpense", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "ovtz_Covid19Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents COVID-19.", "label": "COVID-19 [Member]" } } }, "localname": "Covid19Member", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the employee and directors of the company.", "label": "Employee and Directors [Member]" } } }, "localname": "EmployeeAndDirectorsMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfDecember212023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of December 21, 2023.", "label": "Employee Stock Option, Expiration Date of December 21, 2023 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfDecember212023Member", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJanuary292024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of January 29, 2024.", "label": "Employee Stock Option, Expiration Date of January 29, 2024 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJanuary292024Member", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJuly212023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of July 21, 2023.", "label": "Employee Stock Option, Expiration Date of July 21, 2023 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJuly212023Member", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJune102024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of June 10, 2024.", "label": "Employee Stock Option, Expiration Date of June10, 2024 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJune102024Member", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EquityOfferingNumberOfCommonSharesPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of common shares per unit in the equity offering.", "label": "ovtz_EquityOfferingNumberOfCommonSharesPerUnit", "terseLabel": "Equity Offering, Number of Common Shares Per Unit (in shares)" } } }, "localname": "EquityOfferingNumberOfCommonSharesPerUnit", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingNumberOfUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of units issued during the period in the equity offering.", "label": "ovtz_EquityOfferingNumberOfUnitsIssued", "terseLabel": "Equity Offering, Number of Units Issued (in shares)" } } }, "localname": "EquityOfferingNumberOfUnitsIssued", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingNumberOfWarrantsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrant per unit in the equity offering.", "label": "ovtz_EquityOfferingNumberOfWarrantsPerUnit", "terseLabel": "Equity Offering, Number of Warrants Per Unit (in shares)" } } }, "localname": "EquityOfferingNumberOfWarrantsPerUnit", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingPricePerUnitIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per unit issued in the equity offering.", "label": "ovtz_EquityOfferingPricePerUnitIssued", "terseLabel": "Equity Offering, Price Per Unit Issued (in CAD per share)" } } }, "localname": "EquityOfferingPricePerUnitIssued", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "ovtz_FilingAndRegulatoryFee": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 4.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for filing and regulatory.", "label": "Filing and regulatory fees" } } }, "localname": "FilingAndRegulatoryFee", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "ovtz_InvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the investors of the company.", "label": "Investors [Member]" } } }, "localname": "InvestorsMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_NoteToFinancialStatementDetailsTextual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "localname": "NoteToFinancialStatementDetailsTextual", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_OCLTechnologiesCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents OCL Technologies Corp.", "label": "OCL Technologies Corp [Member]" } } }, "localname": "OCLTechnologiesCorpMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_RollingStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the Rolling Stock Option Plan.", "label": "Rolling Stock Option Plan [Member]" } } }, "localname": "RollingStockOptionPlanMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of selling, general and administrative expenses.", "label": "Schedule of Selling, General and Administrative Expenses [Table Text Block]" } } }, "localname": "ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables" ], "xbrltype": "textBlockItemType" }, "ovtz_SellingGeneralAndAdministrativeDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for selling, general and administrative expenses.", "label": "Selling, General and Administrative Disclosure [Text Block]" } } }, "localname": "SellingGeneralAndAdministrativeDisclosureTextBlock", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative" ], "xbrltype": "textBlockItemType" }, "ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the fair value of options under the share-based compensation.", "label": "ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percent of issued and outstanding common shares reserved in a share-based compensation.", "label": "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "terseLabel": "Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved" } } }, "localname": "SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "ovtz_VestingEverySixMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the options vested every 6 months.", "label": "Vesting Every Six Months [Member]" } } }, "localname": "VestingEverySixMonthsMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_WarrantsIssuedInConnectionWithBusinessAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrants issued in connection with business acquisition.", "label": "Warrants Issued in Connection With Business Acquisition [Member]" } } }, "localname": "WarrantsIssuedInConnectionWithBusinessAcquisitionMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details" ], "xbrltype": "domainItemType" }, "ovtz_WarrantsIssuedInConnectionWithPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the warrants issued in connection with the private placement.", "label": "Warrants Issued in Connection with Private Placement [Member]" } } }, "localname": "WarrantsIssuedInConnectionWithPrivatePlacementMember", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of difference between Current Assets and Current Liabilities.", "label": "ovtz_WorkingCapitalDeficit", "terseLabel": "Working Capital (Deficit)" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.oculusvisiontech.com/20210930", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_statement-statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)" } } }, "localname": "statement-statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-3-prepaid-expenses-and-other-current-assets-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Prepaid Expenses and Other Current Assets" } } }, "localname": "statement-statement-note-3-prepaid-expenses-and-other-current-assets-tables", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)" } } }, "localname": "statement-statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-4-accounts-payable-and-accrued-expenses-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Accounts Payable and Accrued Expenses" } } }, "localname": "statement-statement-note-4-accounts-payable-and-accrued-expenses-tables", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price Allocation (Details)" } } }, "localname": "statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details)" } } }, "localname": "statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.) - Purchase Price (Details) (Parentheticals)" } } }, "localname": "statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Acquisition of Complytrust Inc. (Formerly Ocl Technologies Corp.)" } } }, "localname": "statement-statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)" } } }, "localname": "statement-statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-8-selling-general-and-administrative-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 - Selling, General and Administrative" } } }, "localname": "statement-statement-note-8-selling-general-and-administrative-tables", "nsuri": "http://www.oculusvisiontech.com/20210930", "xbrltype": "stringItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r29", "r31", "r63", "r64", "r116", "r119" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r30", "r31", "r63", "r64", "r116", "r119" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Current, Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r21", "r197" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": 0.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "us-gaap_AccountsPayableCurrent", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r9", "r10", "r24" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued fees and expenses" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r140", "r142", "r160", "r161" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r131", "r133" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "negatedLabel": "Share issuance costs - cash" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r115", "r131", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Contingent consideration" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r142", "r152", "r159" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-based Payment Arrangement, Expense", "verboseLabel": "Stock-based compensation (Note 7)" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r61", "r82", "r85", "r90", "r96", "r102", "r103", "r104", "r106", "r107", "r108", "r109", "r110", "r111", "r113", "r114", "r177", "r179", "r185", "r195", "r197", "r200", "r206" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r143", "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r138", "r139", "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r172", "r173", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Total Purchase Price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r172", "r173" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Common stock issued on acquisition", "terseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r170" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r170" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "negatedLabel": "Accounts payable and due from related party" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r170" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Intangible asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "totalLabel": "Total Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r43" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash acquired on asset acquisition" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r19", "r54" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r47", "r54", "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r47", "r186" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r134", "r141" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "us-gaap_ClassOfWarrantOrRightOutstanding", "terseLabel": "Class of Warrant or Right, Outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r101", "r203", "r209" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).", "label": "Common Stock Including Additional Paid in Capital [Member]" } } }, "localname": "CommonStockIncludingAdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common stock, no par value (in dollars per share)", "terseLabel": "Common Stock, No Par Value (in dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)", "terseLabel": "Common Stock, Shares Authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r131" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding (in shares)", "terseLabel": "Common Stock, Shares, Outstanding, Ending Balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r197" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 86,522,569" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r38" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "us-gaap_CostsAndExpenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r21", "r62", "r105", "r107", "r108", "r112", "r113", "r114", "r194" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable and accrued expenses - related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net loss per share - basic and diluted (in dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r34", "r35", "r36", "r65", "r66", "r67", "r69", "r74", "r76", "r79", "r97", "r131", "r133", "r154", "r155", "r156", "r164", "r165", "r182", "r187", "r188", "r189", "r190", "r191", "r192", "r212", "r213", "r214", "r224" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 2.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Office and administration" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r52", "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill", "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill), Total" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r49", "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid during the period for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r28", "r202", "r210" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": 0.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Tax Receivable \u2013 Canadian GST" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r51" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Decrease (increase) in accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r51" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Decrease (increase) in accounts payable and accrued expenses due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r51" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Decrease in prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r205" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r46", "r48", "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r61", "r96", "r185", "r197", "r201", "r208" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r61", "r96", "r102", "r103", "r104", "r107", "r108", "r109", "r110", "r111", "r113", "r114", "r178", "r179", "r180", "r185", "r195", "r196", "r197" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "us-gaap_LiabilitiesCurrent", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 1.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Marketing" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r2", "r176" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r47" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r47" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r47", "r50", "r53" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r32", "r33", "r36", "r37", "r53", "r61", "r68", "r70", "r71", "r72", "r73", "r75", "r76", "r77", "r82", "r84", "r86", "r89", "r91", "r96", "r102", "r103", "r104", "r107", "r108", "r109", "r110", "r111", "r113", "r114", "r183", "r185", "r204", "r211" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "us-gaap_NetIncomeLoss", "terseLabel": "Net Income (Loss) Attributable to Parent, Total", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": { "auth_ref": [ "r56", "r57", "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1", "negatedLabel": "Intangible acquired on acquisition" } } }, "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1": { "auth_ref": [ "r56", "r57", "r58" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Warrants issued on acquisition (in shares)" } } }, "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1": { "auth_ref": [ "r56", "r57", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Account payable acquired on acquisition" } } }, "localname": "NoncashOrPartNoncashAcquisitionPayablesAssumed1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "us-gaap_NonoperatingIncomeExpense", "totalLabel": "Nonoperating Income (Expense), Total" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r82", "r84", "r86", "r89", "r91" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r193" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 3.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Rent" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r181" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash financing and investing activities" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r45" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "us-gaap_PaymentsOfStockIssuanceCosts", "negatedLabel": "Share issuance costs", "terseLabel": "Payments of Stock Issuance Costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r143", "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r11", "r117" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, no par value (in dollars per share)" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r11", "r117" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11", "r197" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock - no par value; authorized 250,000,000 shares, none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r7", "r17", "r18" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Prepaid Expense and Other Assets, Current" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r8", "r98", "r99" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r44" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "us-gaap_ProceedsFromIssuanceOrSaleOfEquity", "terseLabel": "Proceeds from Issuance or Sale of Equity, Total" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r217", "r218" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 0.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r163", "r198", "r219" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r133", "r157", "r197", "r207", "r215", "r216" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "terseLabel": "Retained Earnings (Accumulated Deficit), Ending Balance" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r65", "r66", "r67", "r69", "r74", "r76", "r97", "r154", "r155", "r156", "r164", "r165", "r182", "r212", "r214" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r80", "r81", "r83", "r87", "r88", "r92", "r93", "r94", "r136", "r137", "r199" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r39" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited": { "order": 0.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative (Note 8)", "totalLabel": "Selling, General and Administrative Expense, Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r51" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Add back non-cash share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r141", "r145" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r147", "r158" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "us-gaap_SharesIssued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "us-gaap_SharesIssuedPricePerShare", "terseLabel": "Shares Issued, Price Per Share (in CAD per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r27", "r34", "r35", "r36", "r65", "r66", "r67", "r69", "r74", "r76", "r79", "r97", "r131", "r133", "r154", "r155", "r156", "r164", "r165", "r182", "r187", "r188", "r189", "r190", "r191", "r192", "r212", "r213", "r214", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r65", "r66", "r67", "r79", "r199" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-allocation-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-purchase-price-details-parentheticals", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r11", "r12", "r133" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Shares issued for asset acquisition (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r131", "r133" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Sale of common stock (in shares)", "terseLabel": "Stock Issued During Period, Shares, New Issues (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r27", "r131", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Shares issued for asset acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r131", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Sale of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r14", "r15", "r61", "r95", "r96", "r185", "r197" ], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "us-gaap_StockholdersEquity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-stockholders-equity-unaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r60", "r118", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r133", "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-2-going-concern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-cash-flows-unaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "localname": "TableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-4-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-tables", "http://www.oculusvisiontech.com/20210930/role/statement-note-8-selling-general-and-administrative-tables" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemAxis": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Axis]" } } }, "localname": "UnusualOrInfrequentItemAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemDomain": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Domain]" } } }, "localname": "UnusualOrInfrequentItemDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "domainItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-9-covid19" ], "xbrltype": "textBlockItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20210930/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Commitment to issue shares", "terseLabel": "Warrants and Rights Outstanding" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited", "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_WarrantsAndRightsOutstandingTerm", "terseLabel": "Warrants and Rights Outstanding, Term (Year)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-note-5-acquisition-of-complytrust-inc-formerly-ocl-technologies-corp-details-textual", "http://www.oculusvisiontech.com/20210930/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted average number of common shares outstanding \u2013 basic and diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.oculusvisiontech.com/20210930/role/statement-consolidated-statements-of-operations-unaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r221": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r222": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r223": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r42": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/subtopic&trid=114868817" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" } }, "version": "2.1" } ZIP 49 0001437749-21-025797-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-025797-xbrl.zip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end